| 2025 |
Jahan, S., Lindsay, D., Diaz, A., Li, M., Griffiths, K., Olver, I., & Garvey, G. (2025). End-of-life healthcare use and associated costs for First Nations Australians diagnosed with cancer in Queensland, Australia. Supportive Care in Cancer, 33(8), 669-1-669-10. DOI |
| 2025 |
Owais, S. S., Arnolda, G., Lamprell, K., Liauw, W., Delaney, G. P., Olver, I., . . . Braithwaite, J. (2025). Bowel cancer diagnosis experiences as a predictor of overall care rating: evidence from the English Cancer Patient Experience Survey. Frontline Gastroenterology, 16(2), 92-100. DOI |
| 2025 |
Dars, S., Tiruye, T., Roder, D., Banwell, H. A., Olver, I., & Beckmann, K. (2025). Patterns and factors associated with podiatry service use among colorectal cancer patients following chemotherapy in South Australia: focus on Chemotherapy-Induced Peripheral Neuropathy (CIPN). Journal of Multidisciplinary Healthcare, 18, 6361-6372. DOI |
| 2025 |
Kemp, E., Ugalde, A., Marshall, S., Grech, L., Ramsey, I., Kirk, D., . . . Koczwara, B. (2025). Factors associated with employment outcomes in cancer survivors: a systematic scoping review spanning a decade of international research. Supportive Care in Cancer, 33(11), 11 pages. DOI |
| 2025 |
Glewis, S., Michael, M., Gurney, H., Olver, I., Zdenkowski, N., Ackland, S., . . . Martin, J. H. (2025). Feasibility and population exposure of 5-fluorouracil using therapeutic drug monitoring (PREDICT-5FU): A multicentre clinical trial. British Journal of Clinical Pharmacology, 91(7), 1965-1974. DOI Scopus2 WoS2 Europe PMC3 |
| 2024 |
Lamba, G. T., LaBrooy, C., Lewis, S., Olver, I., Holmes, A., Stewart, C., & Komesaroff, P. (2024). Voluntary assisted dying: impacts on health professionals. Australian Health Review, 48(6), 720-728. DOI Scopus4 WoS4 Europe PMC3 |
| 2024 |
Bowden, J. A., Bartram, A., Harrison, N. J., Norris, C. A., Kim, S., Pettigrew, S., . . . Room, R. (2024). Australian parents' attitudes, perceptions and supply of alcohol to adolescents: a national cross-sectional survey. Health Promotion International, 39(6), daae173-1-daae173-10. DOI Scopus1 WoS1 Europe PMC1 |
| 2024 |
Olver, I. N. (2024). Ethics of artificial intelligence in supportive care in cancer. Medical Journal of Australia, 220(10), 499-501. DOI Scopus2 WoS1 |
| 2024 |
Lamprell, K., Chittajallu, R., Arnolda, G., Easpaig, B. N. G., Delaney, G. P., Liauw, W., . . . Braithwaite, J. (2024). Multidisciplinary team meeting Chairs' attitudes and perceived facilitators, barriers and ideal improvements to meeting functionality: A qualitative study. Asia-Pacific Journal of Clinical Oncology, 20(4), 537-545. DOI Scopus4 WoS4 Europe PMC1 |
| 2024 |
Ostwal, V., Ramaswamy, A., Mandavkar, S., Bhargava, P., Naughane, D., Sunn, S. F., . . . Olver, I. (2024). Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy A Phase 3 Randomized Clinical Trial. JAMA Network Open, 7(8), 11 pages. DOI Scopus8 WoS8 Europe PMC10 |
| 2024 |
Grimison, P., Mersiades, A., Kirby, A., Tognela, A., Olver, I., Morton, R. L., . . . Stockler, M. R. (2024). Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial. Journal of Clinical Oncology, 42(34), 4040-4050. DOI Scopus15 WoS12 Europe PMC16 |
| 2024 |
Kim, G. Y., Conduit, C., O’Haire, S., Chong, C. Y., Baenziger, O., Lewin, J., . . . Tran, B. (2024). Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysis. Basic and Clinical Andrology, 34(1), 7 pages. DOI Scopus1 WoS2 Europe PMC1 |
| 2024 |
Chan, R. J., Knowles, R., Ashbury, F. D., Bowen, J., Chan, A., Chin, M., . . . Lustberg, M. (2024). Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study. EClinicalMedicine, 76, 102825-1-102825-12. DOI Scopus13 WoS12 Europe PMC8 |
| 2024 |
Olver, I., Clark-Snow, R., Ruhlmann, C. H., Garcia-del-Barrio, M. A., Schwartzberg, L., Rapoport, B. L., & Jahn, F. (2024). 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive Care in Cancer, 32(1), 5 pages. DOI Scopus5 WoS5 Europe PMC3 |
| 2024 |
Molassiotis, A., Affronti, M. L., Fleury, M., Olver, I., Giusti, R., & Scotte, F. (2024). 2023 MASCC/ESMO consensus antiemetic guidelines related to integrative and non-pharmacological therapies. Supportive Care in Cancer, 32(1), 8 pages. DOI Scopus10 WoS6 Europe PMC6 |
| 2024 |
Bartram, A., Harrison, N. J., Norris, C. A., Kim, S., Pettigrew, S., Room, R., . . . Bowden, J. A. (2024). Which parents provide zero-alcohol beverages to adolescents? A survey of Australian parents' practices and intentions. Preventive Medicine, 179, 107840-1-107840-8. DOI Scopus8 WoS8 Europe PMC6 |
| 2024 |
Yip, R., Arnolda, G., Lamprell, K., Nic Giolla Easpaig, B., Chittajallu, R., Delaney, G., . . . Braithwaite, J. (2024). Experience of patients considering or using checkpoint inhibitors in cancer treatment: a systematic review of qualitative research. Journal for ImmunoTherapy of Cancer, 12(1), e007555-1-e007555-14. DOI Scopus3 WoS3 Europe PMC4 |
| 2024 |
Lewis, S., La Brooy, C., Kerridge, I., Holmes, A., Olver, I., Hudson, P., . . . Komesaroff, P. (2024). Choreographing a good death: Carers' experiences and practices of enacting assisted dying. Sociology of Health and Illness, 46(7), 1345-1363. DOI Scopus6 WoS7 Europe PMC3 |
| 2024 |
Harrison, N. J., Norris, C. A., Bartram, A., Murphy, M., Pettigrew, S., Dell, A. O., . . . Bowden, J. A. (2024). "They start on the zero-alcohol and they wanna try the real thing": Parents' views on zero-alcohol beverages and their use by adolescents. Australian and New Zealand Journal of Public Health, 48(3), 100119-1-100119-10. DOI Scopus8 WoS6 Europe PMC2 |
| 2024 |
Herrstedt, J., Clark-Snow, R., Ruhlmann, C. H., Molassiotis, A., Olver, I., Rapoport, B. L., . . . Scotté, F. (2024). 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. ESMO Open, 9(2), 18 pages. DOI Scopus77 WoS71 Europe PMC60 |
| 2023 |
De Groef, A., Evenepoel, M., Van Dijck, S., Dams, L., Haenen, V., Wiles, L., . . . Meeus, M. (2023). Feasibility and pilot testing of a personalized eHealth intervention for pain science education and self-management for breast cancer survivors with persistent pain: a mixed-method study. Supportive Care in Cancer, 31(2, article no. 119), 1-22. DOI Scopus25 WoS26 Europe PMC21 |
| 2023 |
Owais, S. S., Arnolda, G., Lamprell, K., Liauw, W., Delaney, G. P., Olver, I., . . . Braithwaite, J. (2023). Age-related experiences of colorectal cancer diagnosis: a secondary analysis of the English National Cancer Patient Experience Survey. BMJ Open Gastroenterology, 10(1), e001066-1-e001066-12. DOI Scopus3 WoS3 Europe PMC2 |
| 2023 |
Semenenko, E., Banerjee, S., Olver, I., & Ashinze, P. (2023). Review of psychological interventions in patients with cancer. Supportive Care in Cancer, 31(4), 10 pages. DOI Scopus19 WoS18 Europe PMC17 |
| 2023 |
Treleaven, L., Komesaroff, P., La Brooy, C., Olver, I., Kerridge, I., & Philip, J. (2023). A review of the utility of prognostic tools in predicting 6-month mortality in cancer patients, conducted in the context of voluntary assisted dying. Internal Medicine Journal, 53(12), 2180-2197. DOI Scopus3 WoS3 Europe PMC2 |
| 2023 |
Ahmed, M., Mäkinen, V. -P., Lumsden, A., Boyle, T., Mulugeta, A., Lee, S. H., . . . Hyppönen, E. (2023). Metabolic profile predicts incident cancer: A large-scale population study in the UK Biobank.. Metabolism: clinical and experimental, 138(155342), 1-9. DOI Scopus8 WoS8 Europe PMC6 |
| 2023 |
Madakkatel, I., Lumsden, A. L., Mulugeta, A., Olver, I., & Hyppönen, E. (2023). Hypothesis-free discovery of novel cancer predictors using machine learning. European Journal of Clinical Investigation, 53(10), 1-13. DOI Scopus4 WoS4 Europe PMC4 |
| 2023 |
Skaczkowski, G., Barrett, A., Olver, I., Dollman, J., & Gunn, K. M. (2023). 'It is a life changing experience': the experiences of living kidney donors who live in rural Australia. Australian Journal Of Rural Health, 31(5), 866-877. DOI Scopus4 WoS4 Europe PMC4 |
| 2023 |
Molassiotis, A., Zhao, I. Y., Crichton, M., Olver, I., Fleury, M., Giusti, R., . . . Affronti, M. L. (2023). Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic review. Supportive Care in Cancer, 31(7), 19 pages. DOI Scopus9 WoS8 Europe PMC7 |
| 2023 |
Philip, J., Le, B., La Brooy, C., Olver, I., Kerridge, I., & Komesaroff, P. (2023). Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?. Current Treatment Options in Oncology, 24(10), 1351-1364. DOI Scopus4 WoS7 Europe PMC2 |
| 2023 |
Philip, J., Le, B., La Brooy, C., Olver, I., Kerridge, I., & Komesaroff, P. (2023). Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years? (Current Treatment Options in Oncology, (2023), 24, 10, (1351-1364), 10.1007/s11864-023-01126-8). Current Treatment Options in Oncology, 24(10), 1365-1366. DOI |
| 2023 |
van der Kruk, S., Harrison, N. J., Bartram, A., Newton, S., Miller, C., Room, R., . . . Bowden, J. (2023). Prevalence of parental supply of alcohol to minors: a systematic review. Health Promotion International, 38(5), 1-25. DOI Scopus6 WoS6 Europe PMC6 |
| 2023 |
van der Kruk, S., Harrison, N. J., Bartram, A., Newton, S., Miller, C., Room, R., . . . Bowden, J. (2023). Prevalence of parental supply of alcohol to minors: a systematic review (vol 38, daad111, 2023). HEALTH PROMOTION INTERNATIONAL, 38(6), 1 page. DOI |
| 2023 |
De Groef, A., Meeus, M., Heathcote, L. C., Wiles, L., Catley, M., Vogelzang, A., . . . Moseley, G. L. (2023). Treating persistent pain after breast cancer: practice gaps and future directions. Journal of Cancer Survivorship, 17(6), 1698-1707. DOI Scopus13 WoS12 Europe PMC9 |
| 2022 |
Ward, P. R., Foley, K., Meyer, S. B., Wilson, C., Warin, M., Miller, E. R., . . . Lunnay, B. (2022). How does social class shape women's alcohol stockpiling during COVID-19?: A qualitative study in South Australia during the 2020 lockdown. SSM. Qualitative Research in Health, 2, 100080-1-100080-7. DOI Scopus10 WoS9 Europe PMC9 |
| 2022 |
Huppatz, E., Lunnay, B., Foley, K., Miller, E., Warin, M., Wilson, C., . . . Ward, P. (2022). Adaptive capacity: A qualitative study of midlife Australian women's resilience during COVID-19. SSM. Mental Health, 2, 1-8. DOI Scopus8 WoS2 |
| 2022 |
Lunnay, B., Foley, K., Meyer, S. B., Miller, E. R., Warin, M., Wilson, C., . . . Ward, P. R. (2022). 'I have a healthy relationship with alcohol': Australian midlife women, alcohol consumption and social class. Health Promotion International, 37(4), daac097-1-daac097-12. DOI Scopus32 WoS30 Europe PMC22 |
| 2022 |
Meyer, S. B., Lunnay, B., Warin, M., Foley, K., Olver, I. N., Wilson, C., . . . Ward, P. R. (2022). Examining social class as it relates to heuristics women use to determine the trustworthiness of information regarding the link between alcohol and breast cancer risk. PLoS One, 17(9), 1-19. DOI Scopus16 WoS14 Europe PMC11 |
| 2022 |
Bowden, J., Harrison, N. J., Caruso, J., Room, R., Pettigrew, S., Olver, I., & Miller, C. (2022). Which drinkers have changed their alcohol consumption due to energy content concerns? An Australian survey.. BMC public health, 22(1), 1775. DOI Scopus4 WoS4 |
| 2022 |
Bandiera, C., Skrabal Ross, X., Cardoso, E., Wagner, D., Csajka, C., Olver, I., . . . Schneider, M. (2022). Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland. Supportive Care in Cancer, 30(5), 3655-3659. DOI Scopus1 WoS1 Europe PMC1 |
| 2022 |
Ward, P. R., Foley, K., Meyer, S. B., Wilson, C., Warin, M., Batchelor, S., . . . Lunnay, B. (2022). Place of alcohol in the ‘wellness toolkits’ of midlife women in different social classes: a qualitative study in South Australia. Sociology of Health and Illness, 44(2), 488-507. DOI Scopus34 WoS30 Europe PMC18 |
| 2022 |
Skrabal, R. X., Gunn, K. M., Suppiah, V., Patterson, P., Boyle, T., Carrington, C., . . . Olver, I. (2022). A smartphone program to support adherence to oral chemotherapy in people with cancer: proof-of-concept trial. Asia-Pacific Journal of Clinical Oncology, 18(5), e378-e387. DOI Scopus3 WoS3 Europe PMC3 |
| 2022 |
Nic Giolla Easpaig, B., Tran, Y., Winata, T., Lamprell, K., Fajardo Pulido, D., Arnolda, G., . . . Braithwaite, J. (2022). The complexities, coordination, culture and capacities that characterise the delivery of oncology services in the common areas of ambulatory settings.. BMC health services research, 22(1), 15 pages. DOI Scopus3 WoS3 Europe PMC1 |
| 2022 |
van der Kruk, S. R., Butow, P., Mesters, I., Boyle, T., Olver, I., White, K., . . . Clinical Oncological Society of Australia. (2022). Psychosocial well-being and supportive care needs of cancer patients and survivors living in rural or regional areas: a systematic review from 2010 to 2021.. Support Care Cancer, 30(2), 1021-1064. DOI Scopus62 WoS60 Europe PMC47 |
| 2022 |
Lunnay, B., Nicholls, E., Pennay, A., MacLean, S., Wilson, C., Meyer, S. B., . . . Ward, P. R. (2022). Sober Curiosity: A Qualitative Study Exploring Women’s Preparedness to Reduce Alcohol by Social Class. International Journal of Environmental Research and Public Health, 19(22), 17 pages. DOI Scopus26 WoS19 Europe PMC16 |
| 2022 |
Bierbaum, M., Rapport, F., Arnolda, G., Delaney, G. P., Liauw, W., Olver, I., & Braithwaite, J. (2022). Clinical practice guideline adherence in oncology: A qualitative study of insights from clinicians in Australia. Plos One, 17(12 December), 32 pages. DOI Scopus11 WoS10 Europe PMC11 |
| 2022 |
Chittem, M., Eliott, J., & Olver, I. (2022). Demonstrating the importance of cultural considerations at end of life utilizing the perspective of Indian patients with cancer. Supportive Care in Cancer, 30(3), 2515-2525. DOI Scopus6 WoS5 Europe PMC5 |
| 2022 |
Li, M., Reintals, M., D'Onise, K., Farshid, G., Holmes, A., Joshi, R., . . . Roder, D. M. (2022). Investigating the breast cancer screening-treatment-mortality pathway of women diagnosed with invasive breast cancer: Results from linked health data.. European journal of cancer care, 31(1), 12 pages. DOI Scopus4 WoS3 Europe PMC2 |
| 2021 |
Holden, C. A., Turnbull, D., Frank, O. R., & Olver, I. (2021). General practice perspectives on a bowel cancer screening quality improvement intervention using the Consolidated Framework for Implementation Research. Public Health Research and Practice, 31(3), 1-9. DOI Scopus5 WoS5 Europe PMC5 |
| 2021 |
Ghinea, N., Critchley, C., Morrell, B., Kerridge, I., Campbell, T., Day, R., . . . Lipworth, W. (2021). A survey of Australian public attitudes towards funding of high cost cancer medicines. Health Policy, 125(3), 327-334. DOI Scopus5 WoS5 Europe PMC3 |
| 2021 |
Kida, K., Olver, I., Yennu, S., Tripathy, D., & Ueno, N. T. (2021). Optimal Supportive Care for Patients With Metastatic Breast Cancer According to Their Disease Progression Phase.. JCO oncology practice, 17(4), 177-184. DOI Scopus28 WoS28 Europe PMC22 |
| 2021 |
Olver, I. N., Chin, M., & Lalla, R. V. (2021). Now we are 30: 10 more years of MASCC.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(4), 1713-1718. DOI Scopus1 WoS1 Europe PMC1 |
| 2021 |
Gunn, K. M., Skrabal Ross, X., McLoughlin, M., McDonald, S., & Olver, I. (2021). The psychosocial experiences and supportive care preferences of organ transplant recipients and their carers who live in regional Australia. Australian Journal of Rural Health, 29(1), 92-105. DOI Scopus11 WoS12 Europe PMC10 |
| 2021 |
Skrabal Ross, X., Gunn, K. M., & Olver, I. (2021). Understanding the strategies rural cancer patients and survivors use to manage financial toxicity and the broader implications on their lives.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(9), 10 pages. DOI Scopus13 WoS12 Europe PMC9 |
| 2021 |
Sansom-Daly, U. M., Lobb, E. A., Evans, H. E., Breen, L. J., Ugalde, A., Best, M., . . . PoCoG End of Life Care Special Interest Group. (2021). To be mortal is human: professional consensus around the need for more psychology in palliative care. BMJ Supportive and Palliative Care, 11(4), 002884-1-002884-3. DOI Scopus15 Europe PMC9 |
| 2021 |
Olver, I. (2021). Supportive care practice: do we need guidelines?. Curr Opin Oncol, Publish Ahead of Print(4), 273-278. DOI |
| 2021 |
Li, M., Roder, D., D'Onise, K., Walters, D., Farshid, G., Buckley, E., . . . Olver, I. (2021). Female breast cancer treatment and survival in South Australia: Results from linked health data.. Eur J Cancer Care (Engl), 30(5), 1-12. DOI Scopus3 WoS4 Europe PMC3 |
| 2021 |
Gunn, K. M., Olver, I., Skrabal Ross, X., Harrison, N., Livingston, P. M., & Wilson, C. (2021). Improving Survivors’ Quality of Life Post-Treatment: The Perspectives of Rural Australian Cancer Survivors and Their Carers. Cancers, 13(7), 1600. DOI Scopus26 WoS27 Europe PMC24 |
| 2021 |
Kemp, E., Knott, V., Ward, P., Freegard, S., Olver, I., Fallon-Ferguson, J., . . . Koczwara, B. (2021). Barriers to employment of Australian cancer survivors living with geographic or socio-economic disadvantage: a qualitative study. Health expectations : an international journal of public participation in health care and health policy, 24(3), 951-966. DOI Scopus9 WoS10 Europe PMC7 |
| 2021 |
Lunnay, B., Foley, K., Meyer, S. B., Warin, M., Wilson, C., Olver, I., . . . Ward, P. R. (2021). Alcohol consumption and perceptions of health risks during COVID-19: a qualitative study of middle-aged women in South Australia. Frontiers in Public Health, 9, 1-11. DOI Scopus42 WoS32 Europe PMC22 |
| 2021 |
Beckmann, K., Selva-Nayagam, S., Olver, I., Miller, C., Buckley, E. S., Powell, K., . . . Oehler, M. K. (2021). Carcinosarcomas of the uterus: prognostic factors and impact of adjuvant treatment. Cancer Management and Research, 13, 4633-4645. DOI Scopus7 WoS7 Europe PMC5 |
| 2021 |
Miller, E. R., Olver, I. N., Wilson, C. J., Lunnay, B., Meyer, S. B., Foley, K., . . . Ward, P. R. (2021). COVID-19, alcohol consumption and stockpiling practises in midlife women: repeat surveys during lockdown in Australia and the United Kingdom. Frontiers in Public Health, 9, 1-11. DOI Scopus17 WoS16 Europe PMC14 |
| 2021 |
Lunnay, B., Toson, B., Wilson, C., Miller, E. R., Meyer, S. B., Olver, I. N., . . . Ward, P. R. (2021). Social class and changes in Australian women's affect and alcohol consumption during COVID-19. Frontiers in Public Health, 9, 645376-1-645376-15. DOI Scopus27 WoS24 Europe PMC19 |
| 2021 |
Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., & Bezak, E. (2021). Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose. Head and Neck, 43(10), 3086-3096. DOI Scopus1 WoS1 Europe PMC1 |
| 2021 |
Patel, J. N., Olver, I., & Ashbury, F. (2021). Pharmacogenomics in cancer supportive care: key issues and future directions.. Support Care Cancer, 29(11), 6187-6191. DOI Scopus5 WoS4 Europe PMC2 |
| 2021 |
Nic Giolla Easpaig, B., Tran, Y., Winata, T., Lamprell, K., Fajardo Pulido, D., Arnolda, G., . . . Braithwaite, J. (2021). Providing outpatient cancer care for CALD patients: a qualitative study. BMC Research Notes, 14(1), 304-1-304-8. DOI Scopus5 WoS6 Europe PMC4 |
| 2021 |
Gunn, K. M., Luker, J., Ramanathan, R., Skrabal Ross, X., Hutchinson, A., Huynh, E., & Olver, I. (2021). Choosing and Managing Aged Care Services from Afar: What Matters to Australian Long-Distance Care Givers. International Journal of Environmental Research and Public Health, 18(24), 1-17. DOI Scopus6 WoS6 Europe PMC3 |
| 2021 |
Ward, P. R., Lunnay, B., Foley, K., Meyer, S. B., Thomas, J., Olver, I., & Millere, E. R. (2021). The Case of Australia. The International Journal of Social Quality, 11(1-2), 289-308. DOI Scopus10 |
| 2021 |
Huanhuan, C., Li, M., Wang, M., Roder, D., & Olver, I. (2021). Challenges for ethics committees in biomedical research governance: illustrations from China and Australia. Journal of Medical Ethics and History of Medicine, 14(article no. 25), 1-14. DOI Scopus9 Europe PMC4 |
| 2020 |
Olver, I. N., Gunn, K. M., Knott, V. E., Chong, A., Spronk, K., & Cunningham, J. (2020). Communicating cancer and its treatment to Australian Aboriginal patients with cancer: a qualitative study. Supportive Care in Cancer, 38(15), 1-2. DOI Scopus7 WoS8 Europe PMC4 |
| 2020 |
Gunn, K. M., Ross, X. S., & Olver, I. (2020). Optimizing Rural People's Access to Relevant Cancer Education and Support Using Peer-Led YouTube Films.. Journal of Cancer Education, 37(4), 10 pages. DOI Scopus7 WoS7 Europe PMC5 |
| 2020 |
Martin, J. H., & Olver, I. (2020). Precision medicine-based drug treatment individualization in oncology. British Journal of Clinical Pharmacology, 87(2), 223-226. DOI Scopus10 WoS9 Europe PMC7 |
| 2020 |
Bierbaum, M., Rapport, F., Arnolda, G., Nic Giolla Easpaig, B., Lamprell, K., Hutchinson, K., . . . Braithwaite, J. (2020). Clinicians' attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: A systematic review of qualitative and quantitative literature. Implementation Science, 15(1), 24 pages. DOI Scopus76 WoS74 Europe PMC67 |
| 2020 |
Polo, T. C. F., Corrente, J. E., Miot, L. D. B., Papini, S. J., & Miot, H. A. (2020). Dietary patterns of patients with psoriasis at a public healthcare institution in Brazil. Anais Brasileiros De Dermatologia, 95(4), 452-458. DOI Scopus17 WoS16 Europe PMC15 |
| 2020 |
Holden, C. A., Frank, O., Caruso, J., Turnbull, D., Reed, R. L., Miller, C. L., & Olver, I. (2020). From participation to diagnostic assessment: a systematic scoping review of the role of the primary healthcare sector in the National Bowel Cancer Screening Program.. Aust J Prim Health, 26(3), 191-206. DOI Scopus6 WoS5 Europe PMC4 |
| 2020 |
Li, M., Roder, D., D'Onise, K., Walters, D., Farshid, G., Buckley, E., . . . Olver, I. (2020). Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study. BMJ Open, 10(6), e037069. DOI Scopus7 WoS7 Europe PMC4 |
| 2020 |
Young, A. M., Ashbury, F. D., Schapira, L., Scotté, F., Ripamonti, C. I., & Olver, I. N. (2020). Uncertainty upon uncertainty: supportive Care for Cancer and COVID-19.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 28(9), 4001-4004. DOI Scopus60 WoS56 Europe PMC48 |
| 2020 |
Roder, D., Selva-Nayagam, S., Paramasivam, S., Keefe, D., Olver, I., Miller, C., . . . Oehler, M. (2020). Cancers of the corpus uteri treated in South Australian public hospitals: Trends in clinical management and survival across three decades.. Eur J Cancer Care (Engl), 29(5), 1-12. DOI |
| 2020 |
Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., . . . Bezak, E. (2020). Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers.. Cells, 9(8), 1-14. DOI Scopus7 WoS7 Europe PMC6 |
| 2020 |
Holden, C. A., Frank, O., Li, M., Manocha, R., Caruso, J., Turnbull, D., . . . Olver, I. (2020). Engagement of General Practice in an Australian Organised Bowel Cancer Screening Program: A Cross-Sectional Survey of Knowledge and Practice.. Asian Pac J Cancer Prev, 21(7), 2099-2107. DOI Scopus5 Europe PMC3 |
| 2020 |
Olver, I., Carey, M., Bryant, J., Boyes, A., Evans, T., & Sanson-Fisher, R. (2020). Second opinions in medical oncology. BMC Palliative Care, 19(1), 112-1-112-6. DOI Scopus18 WoS17 Europe PMC13 |
| 2020 |
Grimison, P., Mersiades, A., Kirby, A., Lintzeris, N., Morton, R., Haber, P., . . . Stockler, M. (2020). Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV): a randomised, placebo-controlled, phase 2 crossover trial.. Ann Oncol, 31(11), 1553-1560. DOI Scopus111 WoS93 Europe PMC88 |
| 2020 |
Olver, I. N. (2020). Prostate cancer treatment in private and public health services.. Med J Aust, 213(9), 408-409. DOI |
| 2020 |
Nic Giolla Easpaig, B., Tran, Y., Bierbaum, M., Arnolda, G., Delaney, G. P., Liauw, W., . . . Braithwaite, J. (2020). What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence. BMC Health Services Research, 20(1), 102-1-102-24. DOI Scopus75 WoS75 Europe PMC64 |
| 2020 |
Reid, P., Staudacher, A. H., Marcu, L. G., Olver, I., Moghaddasi, L., Brown, M. P., & Bezak, E. (2020). Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers. Scientific Reports, 10(1), 1-8. DOI Scopus12 WoS13 Europe PMC10 |
| 2020 |
Ngwa, W., Olver, I., & Schmeler, K. M. (2020). The Use of Health-Related Technology to Reduce the Gap Between Developed and Undeveloped Regions Around the Globe.. Am Soc Clin Oncol Educ Book, 40(40), 1-10. DOI Europe PMC18 |
| 2020 |
Skrabal Ross, X., Gunn, K. M., Suppiah, V., Patterson, P., & Olver, I. (2020). A review of factors influencing non-adherence to oral antineoplastic drugs. Support Care Cancer, 28(9), 4043-4050. DOI Scopus34 WoS31 Europe PMC22 |
| 2020 |
Olver, I., Keefe, D., Herrstedt, J., Warr, D., Roila, F., & Ripamonti, C. I. (2020). Supportive care in cancer-a MASCC perspective.. Support Care Cancer, 28(8), 3467-3475. DOI Scopus92 WoS87 Europe PMC75 |
| 2020 |
Ghinea, N., Wiersma, M., Kerridge, I., Olver, I., Pearson, S., Day, R., . . . Lipworth, W. (2020). "Some sort of fantasy land": a qualitative investigation of appropriate prescribing in cancer care. Journal of Evaluation in Clinical Practice, 26(3), 747-754. DOI Scopus1 WoS1 Europe PMC1 |
| 2020 |
Whitford, H. S., Kalinowski, P., Schembri, A., Grimison, P., Stockler, M., Martin, A., . . . Australian and New Zealand Urogenital and Prostate Cancer Trials Group. (2020). The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer. Supportive Care in Cancer, 28(7), 3081-3091. DOI Scopus21 WoS21 Europe PMC21 |
| 2019 |
Roder, D., Karapetis, C. S., Olver, I., Keefe, D., Padbury, R., Moore, J., . . . Price, T. (2019). Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival.. BMJ open, 9(9), 1-11. DOI Scopus30 WoS22 Europe PMC24 |
| 2019 |
Nic Giolla Easpaig, B., Arnolda, G., Tran, Y., Bierbaum, M., Lamprell, K., Delaney, G. P., . . . Braithwaite, J. (2019). What is multidisciplinary cancer care like in practice? A protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sector. BMJ Open, 9(10), e031179-1-e031179-10. DOI Scopus4 WoS4 Europe PMC3 |
| 2019 |
Olver, I. (2019). Now We Are 40 – 10 More Years of MOGA. Asia-Pacific Journal of Clinical Oncology, 15(S5), 8-16. DOI Europe PMC1 |
| 2019 |
Li, M., Olver, I., Keefe, D., Holden, C., Worthley, D., Price, T., . . . Roder, D. (2019). Pre-diagnostic colonoscopies reduce cancer mortality - Results from linked population-based data in South Australia. BMC Cancer, 19(1), 856. DOI Scopus10 WoS8 Europe PMC3 |
| 2019 |
Skrabal Ross, X., Gunn, K. M., Olver, I., Willems, R. A., Lechner, L., Mesters, I., & Bolman, C. A. W. (2019). Online psychosocial interventions for posttreatment cancer survivors: an international evidence review and update.. Curr Opin Support Palliat Care, 14(1), 40-50. DOI Scopus34 WoS29 Europe PMC29 |
| 2019 |
Willems, R. A., Bolman, C. A. W., Lechner, L., Mesters, I., Gunn, K. M., Ross, X. S., & Olver, I. (2019). Online interventions aimed at reducing psychological distress in cancer patients: evidence update and suggestions for future directions.. Current opinion in supportive and palliative care, 14(1), 27-39. DOI Scopus31 WoS29 Europe PMC26 |
| 2019 |
Ross, X. S., Gunn, K. M., Patterson, P., & Olver, I. (2019). Development of a smartphone program to support adherence to oral chemotherapy in people with cancer. Patient Preference and Adherence, 13, 2207-2215. DOI Scopus7 WoS6 Europe PMC5 |
| 2019 |
Olver, I., Dodds, S., Kenner, J., Kerridge, I., McGovern, K., Milligan, E., & Mortimer, R. (2019). Ethical considerations relating to healthcare resource allocation decisions. Internal medicine journal, 49(11), 1364-1367. DOI Scopus8 WoS8 Europe PMC4 |
| 2019 |
Meyer, S. B., Foley, K., Olver, I., Ward, P. R., McNaughton, D., Mwanri, L., & Miller, E. R. (2019). Alcohol and breast cancer risk: Middle-aged women's logic and recommendations for reducing consumption in Australia. PLoS ONE, 14(2), 20 pages. DOI Scopus33 WoS30 Europe PMC23 |
| 2019 |
Reid, P., Marcu, L. G., Olver, I., Moghaddasi, L., Staudacher, A. H., & Bezak, E. (2019). Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Radiotherapy and Oncology, 135, 1-12. DOI Scopus33 WoS30 Europe PMC25 |
| 2019 |
Mersiades, A. J., Stockler, M. R., Olver, I. N., & Grimison, P. (2019). Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence. Medical Journal of Australia, 210(1), 11-12.e1. DOI Scopus4 WoS4 Europe PMC3 |
| 2019 |
Olver, I. (2019). Aspirin for the prevention of colorectal cancer. Medicine Today, 20(3), 56-59. |
| 2019 |
Heathcote, L. C., Allen, J. M., Gunn, K. M., Fox, S., Harvie, D. S., Olver, I., . . . Moseley, G. L. (2019). Pain Education for Adolescents and Young Adults Living Beyond Cancer: An Interdisciplinary Meeting Report. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 8(5), 5 pages. DOI Scopus6 WoS9 Europe PMC5 |
| 2019 |
Hall, A., Nguyen, S. M., Mackenzie, L., Sanson-Fisher, R., Olver, I., Thuan, T. V., & Huong, T. T. (2019). What Caused My Cancer? Cancer Patients’ Perceptions on What May Have Contributed to the Development of Their Cancer: A Cross-Sectional, Cross-Country Comparison Study. Cancer Control, 26(1), 10 pages. DOI Scopus9 WoS9 Europe PMC9 |
| 2019 |
Fennell, K. M., Bamford, L., Olver, I., & Wilson, C. J. (2019). Good training, systems and funding, not good luck: what hematologists and oncologists believe would make it easier for them to refer their cancer patients to psychosocial care.. Translational behavioral medicine, 9(1), 139-146. DOI Scopus8 WoS8 Europe PMC6 |
| 2018 |
Karapetis, C. S., Stein, B., Koczwara, B., Harrup, R., Milleshkin, L., Parente, P., . . . Olver, I. (2018). Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying. Internal Medicine Journal, 48(7), 774-779. DOI Scopus24 WoS27 Europe PMC14 |
| 2018 |
Roder, D., Davy, M., Selva-Nayagam, S., Paramasivam, S., Adams, J., Keefe, D., . . . Oehler, M. (2018). Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival. BMC Cancer, 18(1), 10 pages. DOI Scopus6 WoS6 Europe PMC5 |
| 2018 |
Olver, I., Carey, M., Boyes, A., Hall, A., Noble, N., Bryant, J., . . . Sanson-Fisher, R. (2018). The timeliness of patients reporting the side effects of chemotherapy. Supportive Care in Cancer, 26(10), 3579-3586. DOI Scopus23 WoS25 Europe PMC11 |
| 2018 |
Brooks, D., Olver, I. N., & Esterman, A. J. (2018). Beyond PSA testing for prostate cancer. Medical journal of Australia, 208(10), 424-426. DOI Scopus1 WoS2 Europe PMC2 |
| 2018 |
Dhillon, V. S., Yeoh, E., Salisbury, C., Butters, J., Di Matteo, A., Olver, I., & Fenech, M. (2018). Cytokinesis Block Micronucleus Cytome (CBMN Cyt) Assay Biomarkers and Their Association With Radiation Sensitivity Phenotype in Prostate Cancer Cases and DNA Repair Gene hOGG1 (C1245G) Polymorphism. Environmental and Molecular Mutagenesis, 59(9), 813-821. DOI Scopus8 WoS9 Europe PMC5 |
| 2018 |
Olver, I. N. (2018). Improved relative survival of patients with B-cell non-Hodgkin lymphoma in Queensland, 1993-2012. Medical Journal of Australia, 209(4), 157-158. DOI Scopus1 WoS1 |
| 2018 |
Mersiades, A. J., Tognela, A., Haber, P. S., Stockler, M., Lintzeris, N., Simes, J., . . . Grimison, P. (2018). Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV). BMJ open, 8(9), e020745. DOI Scopus21 WoS17 Europe PMC17 |
| 2018 |
Takhar, H., Singhal, N., Mislang, A., Kumar, R., Kim, L., Selva-Nayagam, S., . . . Brown, M. (2018). Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer. Asia-Pacific Journal of Clinical Oncology, 14(1), 91-100. DOI Scopus8 WoS9 Europe PMC6 |
| 2018 |
Smith, A., Rutherford, C., Butow, P., Olver, I., Luckett, T., Grimison, P., . . . King, M. (2018). A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors. Psycho-Oncology, 27(4), 1129-1137. DOI Scopus57 WoS52 Europe PMC45 |
| 2018 |
Olver, I., Shi, Q., Qiao, M., Liu, Y., Pan-Hammarstrom, Q., Wang, J., . . . Lu, Z. -X. (2018). The 150 most important questions in cancer research and clinical oncology series: questions 86-93 abstracts. CANCER COMMUNICATIONS, 37(1), 7 pages. DOI |
| 2018 |
Wilson, C., Flight, I., Zajac, I. T., Turnbull, D., Young, G. P., & Olver, I. (2018). Web-based communication strategies designed to improve intention to minimize risk for colorectal cancer: Randomized controlled trial. JMIR Cancer, 4(1), e2.1-e2.11. DOI Scopus2 WoS2 Europe PMC1 |
| 2018 |
Carey, M., Sanson-Fisher, R., Clinton-McHarg, T., Boyes, A., Olver, I., Oldmeadow, C., . . . Henskens, F. (2018). Examining variation across treatment clinics in cancer patients' psychological outcomes: results of a cross sectional survey. Supportive Care in Cancer, 26(9), 3201-3208. DOI Scopus5 WoS5 Europe PMC3 |
| 2018 |
Olver, I. (2018). Bowel cancer screening for women at midlife. Climacteric, 21(3), 243-248. DOI |
| 2018 |
Ross, X. S., Gunn, K. M., Patterson, P., & Olver, I. (2018). Mobile-based oral chemotherapy adherence–enhancing interventions: Scoping review. JMIR mHealth and uHealth, 6(12), 11 pages. DOI Scopus20 WoS19 Europe PMC16 |
| 2018 |
Skrabal Ross, X., Gunn, K. M., Patterson, P., & Olver, I. (2018). Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review (Preprint). DOI |
| 2018 |
Mersiades, A. J., Stockler, M. R., Olver, I. N., & Grimison, P. (2018). Medicinal cannabis for chemotherapy-induced nausea and vomiting: prescribing with limited evidence.. The Medical journal of Australia. |
| 2018 |
Olver, I. (2018). Preface. Mascc Textbook of Cancer Supportive Care and Survivorship, v-vi. |
| 2017 |
Wilson, C., Flight, I., Zajac, I. T., Turnbull, D., Young, G. P., & Olver, I. (2017). Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial (Preprint). DOI |
| 2017 |
Wilson, C., Flight, I., Zajac, I. T., Turnbull, D., Young, G. P., & Olver, I. (2017). Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial. DOI |
| 2017 |
Olver, I. N. (2017). Rolapitant in the treatment of nausea and vomiting associated with chemotherapy. Clinical Medicine Insights: Therapeutics, 9, 1179559X1771910. DOI WoS1 |
| 2017 |
Carey, M., Boyes, A., Smits, R., Bryant, J., Waller, A., & Olver, I. (2017). Access to clinical trials among oncology patients: results of a cross sectional survey. BMC Cancer, 17(1), 1-8. DOI Scopus19 WoS15 Europe PMC15 |
| 2017 |
Olver, I. (2017). Cancer control-A global perspective. European Journal of Cancer Care, 26(1), 6 pages. DOI Scopus9 WoS7 Europe PMC5 |
| 2017 |
Tattersall, M. H. N., Jefford, M., Martin, A., Olver, I., Thompson, J. F., Brown, R. F., & Butow, P. N. (2017). Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials. BMJ Open, 7(3), 1-7. DOI Scopus13 WoS12 Europe PMC10 |
| 2017 |
So, B., Marcu, L. G., Olver, I., Gowda, R., & Bezak, E. (2017). Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas. Acta Oncologica, 56(7), 899-908. DOI Scopus3 WoS3 Europe PMC2 |
| 2017 |
So, B., Marcu, L., Olver, I., Gowda, R., & Bezak, E. (2017). Oesophageal cancer: Which treatment is the easiest to swallow? A review of combined modality treatments for resectable carcinomas. Critical Reviews in Oncology/Hematology, 113, 135-150. DOI Scopus9 WoS8 Europe PMC5 |
| 2017 |
Lee, Y. C., Kroon, R., Koczwara, B., Haines, I., Francis, K., Millward, M., . . . Mileshkin, L. (2017). Survey of practices around pharmaceutical company funding for continuing professional development among medical oncologists and trainees in Australia. Internal Medicine Journal, 47(8), 888-893. DOI Scopus4 WoS4 Europe PMC4 |
| 2017 |
Heiniger, L. E., Smith, A. B., Olver, I., Grimison, P., Klein, B., Wootten, A., . . . Butow, P. N. (2017). e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer. European Journal of Cancer Care, 26(6), 10 pages. DOI Scopus22 WoS20 Europe PMC20 |
| 2017 |
Olver, I. N., & Roder, D. (2017). History, development and future of cancer screening in Australia. Public Health Research and Practice, 27(3), 1-7. DOI Scopus21 WoS19 Europe PMC15 |
| 2017 |
Williams, J., Lipworth, W., Mayes, C., Olver, I., & Kerridge, I. (2017). Should disclosure of conflicts of interest in medicine be made public? Medical students’ views. Medical Education, 51(12), 1232-1240. DOI Scopus1 WoS1 Europe PMC1 |
| 2017 |
Fennell, K. M., Turnbull, D. A., Bidargaddi, N., Mcwha, J. L., Davies, M., & Olver, I. (2017). The consumer-driven development and acceptability testing of a website designed to connect rural cancer patients and their families, carers and health professionals with appropriate information and psychosocial support. European Journal of Cancer Care, 26(5), 1-15. DOI Scopus32 WoS27 Europe PMC25 |
| 2017 |
Olver, I., Ruhlmann, C. H., Jahn, F., Schwartzberg, L., Rapoport, B., Rittenberg, C. N., & Clark-Snow, R. (2017). 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive Care in Cancer, 25(1), 297-301. DOI Scopus11 WoS8 Europe PMC11 |
| 2017 |
Dupuis, L. L., Roscoe, J. A., Olver, I., Aapro, M., & Molassiotis, A. (2017). 2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy. Supportive Care in Cancer, 25(1), 317-321. DOI Scopus28 WoS29 Europe PMC24 |
| 2016 |
Olver, I. (2016). The importance of supportive care for patients with cancer: supportive care encompasses managing symptoms and side effects before, during and after cancer treatment. Medical Journal of Australia, 204(11), 401-402.e1. DOI Scopus3 Europe PMC3 |
| 2016 |
Olver, I. N. (2016). Ethical issues with xenotransplantation clinical trials. Medical Journal of Australia, 204(6), 212. DOI Scopus5 WoS5 Europe PMC6 |
| 2016 |
Best, M., Butow, P., & Olver, I. (2016). Palliative care specialists’ beliefs about spiritual care. Supportive Care in Cancer, 24(8), 3295-3306. DOI Scopus42 WoS35 Europe PMC28 |
| 2016 |
Olver, I. (2016). Should clinical trials be approached differently for rare cancers?. Future Oncology, 12(10), 1207-1209. DOI Scopus1 WoS2 Europe PMC1 |
| 2016 |
Mayes, C., Blakely, B., Kerridge, I., Komesaroff, P., Olver, I., & Lipworth, W. (2016). On the fragility of medical virtue in a neoliberal context: the case of commercial conflicts of interest in reproductive medicine. Theoretical Medicine and Bioethics, 37(1), 97-111. DOI Scopus6 WoS8 Europe PMC5 |
| 2016 |
Miller, E., Ramsey, I., Baratiny, G., & Olver, I. (2016). Message on a bottle: are alcohol warning labels about cancer appropriate?. BMC Public Health, 16(1), 1-10. DOI Scopus34 WoS34 Europe PMC25 |
| 2016 |
Olver, I. (2016). Prevention of breast cancer. Medical Journal of Australia, 205(10), 475-479. DOI Scopus15 WoS9 Europe PMC12 |
| 2016 |
Olver, I. (2016). New initiatives in the treatment of breast cancer. The Medical journal of Australia, 205(10), 449-450. DOI Scopus4 WoS4 Europe PMC4 |
| 2016 |
Roila, F., Molassiotis, A., Herrstedt, J., Aapro, M., Gralla, R., Bruera, E., . . . on, B. O. T. P. O. T. M. C. C. C. (2016). 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy- induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Annals of Oncology, 27(suppl. 5), v119-v133. DOI Scopus507 WoS447 Europe PMC380 |
| 2016 |
Best, M., Butow, P., & Olver, I. (2016). Why do We Find It so Hard to Discuss Spirituality? A Qualitative Exploration of Attitudinal Barriers. JOURNAL OF CLINICAL MEDICINE, 5(9), 10 pages. DOI Scopus62 WoS53 Europe PMC37 |
| 2016 |
Olver, I., & Eliott, J. (2016). Translating into practice cancer patients’ views on do-not-resuscitate decision-making. Cancers, 8(10), 89. DOI Scopus4 WoS4 Europe PMC4 |
| 2016 |
Best, M., Butow, P., & Olver, I. (2016). Doctors discussing religion and spirituality: A systematic literature review. Palliative Medicine, 30(4), 327-337. DOI Scopus171 WoS147 Europe PMC103 |
| 2016 |
Smith, A. B., Butow, P., Olver, I., Luckett, T., Grimison, P., Toner, G. C., . . . King, M. T. (2016). The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study. Journal of Cancer Survivorship, 10(2), 223-233. DOI Scopus64 WoS56 Europe PMC46 |
| 2016 |
Olver, I., von Dincklage, J., Nicholson, J., & Shaw, T. (2016). Improving uptake of wiki-based guidelines with Qstream education. Medical Education, 50(5), 590-591. DOI Scopus3 WoS3 Europe PMC2 |
| 2016 |
Best, M., Butow, P., & Olver, I. (2016). Creating a safe space: a qualitative inquiry into the way doctors discuss spirituality. Palliative and Supportive Care, 14(5), 519-531. DOI Scopus36 WoS26 Europe PMC24 |
| 2016 |
Miller, E., Ramsey, I., Tran, L., Tsourtos, G., Baratiny, G., Manocha, R., & Olver, I. (2016). How Australian general practitioners engage in discussions about alcohol with their patients: a cross-sectional study. BMJ Open, 6(12), e013921-1-e013921-10. DOI Scopus15 WoS14 Europe PMC10 |
| 2016 |
Olver, I. (2016). Ethics and cancer. Cancer Forum, 40(2), 95-97. Scopus1 WoS1 |
| 2016 |
Koczwara, B., Gordon, L., & Olver, I. (2016). Financial toxicity in clinical care today: a "menu without prices". The Medical journal of Australia, 205(11), 529. DOI Scopus2 WoS2 Europe PMC1 |
| 2016 |
Olver, I. N. (2016). The importance of supportive care for patients with cancer. MEDICAL JOURNAL OF AUSTRALIA, 204(11), 401-+. DOI WoS3 |
| 2015 |
Olver, I. N. (2015). The whole 9 years. MEDICAL JOURNAL OF AUSTRALIA, 202(8), 450-+. DOI |
| 2015 |
Olver, I. N. (2015). Reassessing rare cancers. MEDICAL JOURNAL OF AUSTRALIA, 203(10), 1-+. DOI |
| 2015 |
Olver, I. N., & Whitford, H. S. (2015). THE IMPACT OF HOPE ON PHYSICAL AND MENTAL HEALTH RESILIENCE IN ONCOLOGY: FINDINGS FROM THE 20/20 VISION FOR CANCER PROJECT. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 11, 61. |
| 2015 |
Best, M., Aldridge, L., Butow, P., Olver, I., Price, M., & Webster, F. (2015). Treatment of holistic suffering in cancer: A systematic literature review. Palliative Medicine, 29(10), 885-898. DOI Scopus28 WoS21 Europe PMC16 |
| 2015 |
Best, M., Aldridge, L., Butow, P., Olver, I., Price, M., & Webster, F. (2015). Assessment of spiritual suffering in the cancer context: A systematic literature review. Palliative & Supportive Care, 13(5), 1335-1361. DOI Scopus57 WoS48 Europe PMC34 |
| 2015 |
Olver, I. (2015). Highlights of PSA testing guidelines. Cancer Forum, 39(3), 161-163. Scopus2 WoS2 |
| 2015 |
Olver, I., & Marshall, V. (2015). Across the spectrum of prostate cancer. Cancer Forum, 39(3), 159-161. |
| 2015 |
Best, M., Butow, P., & Olver, I. (2015). Do patients want doctors to talk about spirituality? A systematic literature review. Patient Education and Counseling, 98(11), 1320-1328. DOI Scopus205 WoS176 Europe PMC146 |
| 2015 |
Olver, I. N. (2015). The whole 9 years. Medical journal of Australia, 202(8), 450-452. DOI |
| 2015 |
Olver, I. N. (2015). Reassessing rare cancers. Medical Journal of Australia, 203(10), 386-1-386-1.e1. DOI Scopus2 WoS1 Europe PMC2 |
| 2015 |
Carrera, P., & Olver, I. (2015). The financial hazard of personalized medicine and supportive care. Supportive Care in Cancer, 23(12), 3399-3401. DOI Scopus28 WoS25 Europe PMC21 |
| 2015 |
Olver, I. (2015). Role of rolapitant in chemotherapy-induced emesis. The Lancet Oncology, 16(9), 1006-1007. DOI Scopus8 WoS6 Europe PMC3 |
| 2015 |
Louise, J., Eliott, J., Olver, I., & Braunack-Mayer, A. (2015). Mandatory cancer risk warnings on alcoholic beverages: what are the ethical issues?. The American Journal of Bioethics, 15(3), 3-11. DOI Scopus19 WoS19 Europe PMC15 |
| 2015 |
Whiteman, D., Appleyard, M., Bahin, F., Bobryshev, Y., Bourke, M., Brown, I., . . . Yusoff, I. (2015). Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. Journal of Gastroenterology and Hepatology (Australia), 30(5), 804-820. DOI Scopus113 WoS99 Europe PMC89 |
| 2015 |
Lovell, M., Luckett, T., Boyle, F., Stubbs, J., Phillips, J., Davidson, P., . . . Agar, M. (2015). Adaptation of international guidelines on assessment and management of cancer pain for the Australian context. Asia-Pacific Journal of Clinical Oncology, 11(2), 170-177. DOI Scopus16 WoS16 Europe PMC13 |
| 2015 |
Best, M., Aldridge, L., Butow, P., Olver, I., & Webster, F. (2015). Conceptual analysis of suffering in cancer: a systematic review. Psycho-Oncology, 24(9), 977-986. DOI Scopus65 WoS55 Europe PMC48 |
| 2015 |
Neuhaus, S., Thomas, D., Desai, J., Vuletich, C., Von Dincklage, J., & Olver, I. (2015). Wiki-based clinical practice guidelines for the management of adult onset sarcoma: A new paradigm in sarcoma evidence. Sarcoma, 2015(614179), 614179. DOI Scopus14 Europe PMC13 |
| 2015 |
Olver, I. (2015). Assessing the burden and management of chemotherapy induced emesis in the Asia/Pacific region. Supportive Care in Cancer, 23(1), 251-252. DOI Scopus3 WoS3 Europe PMC2 |
| 2014 |
Grogan, P. B., & Olver, I. N. (2014). A bowel cancer screening plan at last. Medical Journal of Australia, 201(8), 435-436. DOI Scopus9 WoS8 Europe PMC6 |
| 2014 |
Braun, L., Harris, J., Katris, P., Cain, M., Dhillon, H., Koczwara, B., . . . Robotin, M. (2014). Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients. Asia-Pacific Journal of Clinical Oncology, 10(4), 289-296. DOI Scopus21 WoS19 Europe PMC18 |
| 2014 |
Best, M., Butow, P., & Olver, I. (2014). The doctor's role in helping dying patients with cancer achieve peace: a qualitative study. Palliative Medicine, 28(9), 1139-1145. DOI Scopus31 WoS23 Europe PMC19 |
| 2014 |
Olver, I. N. (2014). Linking data to improve health outcomes: routinely collected data, when linked, are a rich source of sound evidence for making health care decisions. Medical Journal of Australia, 200(7), 368-369. DOI Scopus24 WoS25 Europe PMC18 |
| 2014 |
Olver, I. N. (2014). Opting in for opt-out consent. Medical Journal of Australia, 200(4), 201-202. DOI Scopus13 WoS11 Europe PMC7 |
| 2014 |
Best, M., Butow, P., & Olver, I. (2014). Spiritual support of cancer patients and the role of the doctor. Supportive Care in Cancer, 22(5), 1333-1339. DOI Scopus53 WoS50 Europe PMC34 |
| 2014 |
Whitford, H. S., Jones, S. B. W., & Olver, I. N. (2014). Psychometric properties of the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being, Expanded. QUALITY OF LIFE RESEARCH, 23, 40-41. |
| 2014 |
Whitford, H., & Olver, I. (2014). Convergent Validity of the Newly Proposed Four-Component Structure of the Functional Assessment of Chronic Illness - Spiritual Well-Being, Expanded. PSYCHO-ONCOLOGY, 23, 368-369. |
| 2014 |
Klafke, N., Eliott, J., Olver, I., & Wittert, G. (2014). Australian men with cancer practice complementary therapies (CTs) as a coping strategy. Psycho-Oncology, 23(11), 1236-1242. DOI Scopus16 WoS11 Europe PMC10 |
| 2014 |
Klafke, N., Eliott, J., Olver, I., & Wittert, G. (2014). The varied contribution of significant others to Complementary and Alternative Medicine (CAM) uptake by men with cancer: a qualitative analysis. European Journal of Oncology Nursing (EJON), 18(3), 329-336. DOI Scopus7 WoS7 Europe PMC6 |
| 2014 |
Olver, I., Eliott, J., & Koczwara, B. (2014). A qualitative study investigating chemotherapy-induced nausea as a symptom cluster. Supportive Care in Cancer, 22(10), 2749-2756. DOI Scopus41 WoS37 Europe PMC28 |
| 2014 |
O'Carrigan, B., Fournier, M., Olver, I., Stockler, M., Whitford, H., Toner, G., . . . Australian and New Zealand Urogenital and Prostate Cancer Trials Group. (2014). Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study. Internal Medicine Journal, 44(8), 813-817. DOI Scopus16 WoS15 Europe PMC11 |
| 2014 |
Klafke, N., Eliott, J., Olver, I., & Wittert, G. (2014). The role of complementary and alternative medicine (CAM) routines and rituals in men with cancer and their significant others (SOs): a qualitative investigation. Supportive Care in Cancer, 22(5), 1319-1331. DOI Scopus12 WoS11 Europe PMC11 |
| 2014 |
Olver, I. N. (2014). Linking data to improve health outcomes.. Med J Aust, 200(7), 368-369. DOI |
| 2013 |
Olver, I. N. (2013). Lung cancer: let's try for prevention and cure.. Med J Aust, 199(10), 639-640. DOI |
| 2013 |
Olver, I. (2013). Challenges of accessing cancer medicines in Australia. The Lancet Oncology, 14(11), 1040-1042. DOI Scopus2 WoS2 Europe PMC2 |
| 2013 |
Ramondetta, L., Sun, C., Surbone, A., Olver, I., Ripamonti, C., Konishi, T., . . . Johnson, J. (2013). Surprising results regarding MASCC members' beliefs about spiritual care. Supportive Care in Cancer, 21(11), 2991-2998. DOI Scopus35 WoS31 Europe PMC25 |
| 2013 |
Thaker, D., Monypenny, R., Olver, I., & Sabesan, S. (2013). Cost savings from a telemedicine model of care in northern Queensland, Australia. Medical Journal of Australia, 199(6), 414-417. DOI Scopus117 WoS106 Europe PMC97 |
| 2013 |
Smith, A., King, M., Butow, P., & Olver, I. (2013). A comparison of data quality and practicality of online versus postal questionnaires in a sample of testicular cancer survivors. Psycho-Oncology, 22(1), 233-237. DOI Scopus30 WoS28 Europe PMC23 |
| 2013 |
Smith, A., King, M., Butow, P., Luckett, T., Grimison, P., Toner, G., . . . Olver, I. (2013). The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study. Psycho-Oncology, 22(11), 2557-2564. DOI Scopus64 WoS66 Europe PMC58 |
| 2013 |
Olver, I., & Grogan, P. (2013). Early success for Australia's bowel screening program: let's move it along. Medical Journal of Australia, 198(6), 300-301. DOI Scopus5 WoS4 Europe PMC2 |
| 2013 |
Olver, I., & Keech, A. (2013). Forming networks for research: proposal for an Australian clinical trials alliance. Medical Journal of Australia, 198(5), 254-255. DOI Scopus5 WoS3 Europe PMC3 |
| 2013 |
Gunn, K., Turnbull, D., McWha, J., Davies, M., & Olver, I. (2013). Psychosocial service use: a qualitative exploration from the perspective of rural Australian cancer patients. Supportive Care in Cancer, 21(9), 2547-2555. DOI Scopus54 WoS51 Europe PMC43 |
| 2013 |
Eliott, J., & Olver, I. (2013). Public perceptions of cancer clusters, associated events, and appropriate institutional response. Cancer Forum, 37(1), 93-99. |
| 2013 |
Goldsbury, D., Harris, M., Pascoe, S., Barton, M., Olver, I., Spigelman, A., . . . O'Connell, D. (2013). The varying role of the GP in the pathway between colonoscopy and surgery for colorectal cancer: a retrospective cohort study. BMJ Open, 3(3), 1-11. DOI Scopus3 WoS4 Europe PMC3 |
| 2013 |
Pirri, C., Bayliss, E., Trotter, J., Olver, I., Katris, P., Drummond, P., & Bennett, R. (2013). Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Supportive Care in Cancer, 21(3), 735-748. DOI Scopus65 WoS61 Europe PMC50 |
| 2013 |
Olver, I., Grimison, P., Chatfield, M., Stockler, M., Toner, G., Gebski, V., . . . Thomson, D. (2013). Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy. Supportive Care in Cancer, 21(6), 1561-1568. DOI Scopus34 WoS32 Europe PMC23 |
| 2013 |
Olver, I. N. (2013). Lung cancer: let's try for prevention and cure. Medical Journal of Australia, 199(10), 639-640. DOI |
| 2013 |
Olver, I. N., & von Dincklage, J. J. (2013). It is time for clinical guidelines to enter the digital age. Medical journal of Australia, 199(9), 569-570. DOI Scopus8 WoS6 Europe PMC8 |
| 2013 |
Smith, A. B., King, M., Butow, P., Grimison, P., & Olver, I. (2013). Reduced quality of life in internet-panel controls. Epidemiology, 24(3), 462-463. DOI Scopus3 WoS3 Europe PMC3 |
| 2012 |
Olver, I. N. (2012). Hormone replacement therapy: The need to combine clinical and epidemiological data. Cancer Forum, 36(3), 167-170. |
| 2012 |
Goldsbury, D., Harris, M., Pascoe, S., Olver, I., Barton, M., Spigelman, A., & O'Connell, D. (2012). Socio-demographic and other patient characteristics associated with time between colonoscopy and surgery, and choice of treatment centre for colorectal cancer: A retrospective cohort study. BMJ Open, 2(3), 1-11. DOI Scopus12 WoS12 Europe PMC7 |
| 2012 |
Olver, I. N. (2012). Evolving definitions of hope in oncology. Current opinion in supportive and palliative care, 6(2), 236-241. DOI Scopus30 WoS23 Europe PMC21 |
| 2012 |
Roder, D. M., & Olver, I. N. (2012). Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?. Medical journal of Australia, 196(1), 16. DOI Scopus9 WoS9 Europe PMC6 |
| 2012 |
Olver, I. N. (2012). Women and tobacco: Part of the bigger picture. Tobacco control, 21(2), 243-244. DOI Scopus1 WoS1 Europe PMC1 |
| 2012 |
Olver, I. N., & Young, G. P. (2012). The urgency of saving lives through bowel cancer screening. Medical Journal of Australia, 196(8), 490-491. DOI Scopus3 WoS3 Europe PMC2 |
| 2012 |
Olver, I., Eliott, J., Long, L., McKinnon, M., & Rumsby, G. (2012). The impact of receiving treatment for cancer at a large metropolitan teaching hospital as recorded by patients using unstructured journals. Journal of Cancer Education, 27(4), 625-630. DOI Scopus3 WoS3 Europe PMC3 |
| 2012 |
Whitford, H., & Olver, I. (2012). When expectations predict experience: The influence of psychological factors on chemotherapy toxicities. Journal of Pain and Symptom Management, 43(6), 1036-1050. DOI Scopus29 WoS30 Europe PMC26 |
| 2012 |
Olver, I., & Dutney, A. (2012). A randomized, blinded study of the impact of intercessory prayer on spiritual well-being in patients with cancer. Alternative Therapies in Health and Medicine, 18(5), 18-27. Scopus36 WoS26 Europe PMC13 |
| 2012 |
Isaac, R., Finkel, M., Olver, I., Annie, I., Prashanth, H., Subhashini, J., . . . Trevena, L. (2012). Translating evidence into practice in low resource settings: cervical cancer screening tests are only part of the solution in rural India. Asian Pacific Journal of Cancer Prevention, 13(8), 4169-4172. DOI Scopus20 WoS21 Europe PMC11 |
| 2012 |
Whitford, H., & Olver, I. (2012). The multidimensionality of spiritual wellbeing: peace, meaning, and faith and their association with quality of life and coping in oncology. Psycho-Oncology, 21(6), 602-610. DOI Scopus126 WoS117 Europe PMC86 |
| 2012 |
Knott, V., Turnbull, D., Olver, I., & Winefield, A. (2012). A grounded theory approach to understand the cancer-coping process. British Journal of Health Psychology, 17(3), 551-564. DOI Scopus21 WoS18 Europe PMC12 |
| 2012 |
Klafke, N., Eliott, J., Wittert, G., & Olver, I. (2012). Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services. Annals of Oncology, 23(6), 1571-1578. DOI Scopus63 WoS61 Europe PMC50 |
| 2012 |
Gunn, K., Turnbull, D., Mcwha, L., Davies, M., Bidargaddi, N., & Olver, I. (2012). CONNECTING RURAL CANCER PATIENTS AND THEIR FAMILIES AND CARERS WITH PSYCHOSOCIAL SUPPORT: THE DEVELOPMENT OF A WEBSITE USING A PARTICIPATORY ACTION RESEARCH FRAMEWORK AND BEHAVIOURAL CHANGE THEORY. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 19, S196. |
| 2012 |
Olver, I. (2012). Human Radiation Injury, 1st Edition. CANCER FORUM, 36(2), 117-118. |
| 2011 |
Tan, H., Wilson, A., Olver, I., & Barton, C. (2011). The family meeting addressing spiritual and psychosocial needs in a palliative care setting: Usefulness and challenges to implementation. Progress in Palliative Care, 19(2), 66-72. DOI Scopus3 WoS3 |
| 2011 |
Whitford, H., & Olver, I. (2011). Prayer as a complementary therapy. Cancer Forum, 35(1), 27-30. Scopus5 WoS3 |
| 2011 |
Eliott, J., & Olver, I. (2011). Dying cancer patients talk about physician and patient role in DNR decision making. Health Expectations, 14(2), 147-158. DOI Scopus13 WoS12 Europe PMC10 |
| 2011 |
Tan, H., Wilson, A., Olver, I., & Barton, C. (2011). The experience of palliative patients and their families of a family meeting utilised as an instrument for spiritual and psychosocial care: A qualitative study. BMC Palliative Care, 10(7), 7:1-7:12. DOI Scopus23 WoS25 Europe PMC15 |
| 2011 |
Garvey, G., Cunningham, J., Valery, P., Condon, J., Roder, D., Bailie, R., . . . Olver, I. (2011). Reducing the burden of cancer for Aboriginal and Torres Strait Islander Australians: time for a coordinated, collaborative, priority-driven, Indigenous-led research program. Medical Journal of Australia, 194(10), 530-531. DOI Scopus24 WoS24 Europe PMC18 |
| 2011 |
Olver, I. (2011). Improving cancer treatment by addressing legislative and regulatory issues. Public health, 125(12), 876-881. DOI Scopus3 WoS2 Europe PMC2 |
| 2011 |
Winstanley, M. H., Pratt, I. S., Chapman, K., Griffin, H. J., Croager, E. J., Olver, I. N., . . . Slevin, T. J. (2011). Alcohol and cancer: a position statement from Cancer Council Australia. Medical journal of Australia, 194(9), 479-482. DOI Scopus48 WoS47 Europe PMC32 |
| 2011 |
Olver, I., Marine, F., & Grogan, P. (2011). Disparities in cancer care in Australia and the Pacific. Oncologist, 16(7), 930-934. DOI Scopus21 WoS17 Europe PMC15 |
| 2011 |
Olver, I., Molassiotis, A., Aapro, M., Herrstedt, J., Grunberg, S., & Morrow, G. (2011). Antiemetic research: Future directions. Supportive Care in Cancer, 19(SUPPL. 1), S49-S55. DOI Scopus39 WoS34 Europe PMC30 |
| 2011 |
Olver, I., Clark-Snow, R., Ballatori, E., Espersen, B., Bria, E., & Jordan, K. (2011). Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive Care in Cancer, 19(SUPPL. 1), S33-S36. DOI Scopus11 WoS9 Europe PMC8 |
| 2011 |
Olver, I., Falleiro, S., Marson, M., & Bishop, J. (2011). A case study of a single ethics committee for multicentre trials. Medical Journal of Australia, 195(10), 582-583. DOI Scopus2 WoS2 Europe PMC2 |
| 2011 |
Hegarty, M., Abernethy, A., Olver, I., & Currow, D. (2011). Former palliative caregivers who identify that additional spiritual support would have been helpful in a population survey. Palliative Medicine, 25(3), 266-277. DOI Scopus19 WoS14 Europe PMC11 |
| 2011 |
Olver, I. N. (2011). Cancer clinical trials in Australia. Medical journal of Australia, 194(8), 382-383. DOI Scopus1 WoS1 Europe PMC1 |
| 2011 |
Colagiuri, R., Hill, D. J., Johnson, G. J., Lalor, E., Moodie, R., Olver, I. N., . . . Greenland, R. J. (2011). Time for global action on chronic disease. Medical journal of Australia, 194(4), 158-159. DOI Scopus2 WoS2 Europe PMC2 |
| 2011 |
Roscoe, J., Morrow, G., Aapro, M., Molassiotis, A., & Olver, I. (2011). Anticipatory nausea and vomiting. Supportive Care in Cancer, 19(10), 1533-1538. DOI Scopus144 WoS119 Europe PMC94 |
| 2011 |
Olver, I. N. (2011). Overview of complementary and alternative medicine. Cancer forum, 35(1), 3-6. |
| 2010 |
Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gebski, V. J., . . . Toner, G. C. (2010). Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial. Journal of the National Cancer Institute, 102(16), 1253-1262. DOI Scopus62 WoS48 Europe PMC46 |
| 2010 |
Olver, I. N. (2010). A case study evaluation of ethics review systems for multicentre clinical trials [2]. Medical Journal of Australia, 192(5), 293. DOI |
| 2010 |
Sly, P. D., Chase, R., Kolbe, J., Thompson, P., Gupta, L., Daube, M., . . . Vallance, D. (2010). Asbestos still poses a threat to global health: now is the time for action. Medical Journal of Australia, 193(4), 198-199. DOI Scopus7 WoS7 Europe PMC5 |
| 2010 |
Roila, F., Herrstedt, J., Aapro, M., Gralla, R. J., Olver, I., & Warr, D. (2010). Guideline update for MASCC and ESMO in the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting: Results of the Perugia consensus conference. Annals of oncology, 21(s5), v232-v243. DOI Scopus622 WoS503 Europe PMC427 |
| 2010 |
Dresemann, G., Weller, M., Rosenthal, M. A., Wedding, U., Olver, I. N., & Nikolova, Z. (2010). Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. Journal of neuro-oncology, 96(3), 393-402. DOI Scopus132 WoS123 Europe PMC108 |
| 2010 |
Koczwara, B., Francis, K., Marine, F., Goldstein, D., Underhill, C., & Olver, I. (2010). Reaching further with online education? the development of an effective online program in palliative oncology. Journal of Cancer Education, 25(3), 317-323. DOI Scopus21 WoS20 Europe PMC17 |
| 2010 |
Fitzpatrick, K. L., Boult, M., & Fitridge, R. A. (2010). A case study evaluation of ethics review systems for multicentre clinical trials [1]. Medical Journal of Australia, 192(5), 293. DOI WoS1 |
| 2010 |
Tan, H., Wilson, A., Olver, I., & Barton, C. (2010). Recruiting palliative patients for a large qualitative study: Some ethical considerations and staff dilemmas. Explore: The Journal of Science & Healing, 6(3), 159-165. DOI Scopus13 WoS11 Europe PMC7 |
| 2010 |
Olver, I. (2010). Cancer - Principles & Practice of Oncology Volumes One and Two, 8th Edition. CANCER FORUM, 34(1), 58-59. |
| 2009 |
Olver, I. (2009). MEDICAL ONCOLOGY GROUP OF AUSTRALIA (MOGA)/NOVARTIS CANCER ACHIEVEMENT AWARD. CANCER FORUM, 33(1), 34-36. |
| 2009 |
Tan, H., Wilson, A., & Olver, I. (2009). Ricoeur's Theory of Interpretation: An Instrument for Data Interpretation in Hermeneutic Phenomenology. International Journal of Qualitative Methods, 8(4), 1-15. DOI Scopus91 |
| 2009 |
Gandhi, M. K. (2009). What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?. MEDICAL JOURNAL OF AUSTRALIA, 190(8), 461. DOI WoS1 Europe PMC1 |
| 2009 |
Olver, I. (2009). Reply. Australian Life Scientist, 6(6), 15. |
| 2009 |
Khan, M., Ranson, M., Michael, M., Olver, I. N., Levitt, N. C., Mortimer, P., . . . Middleton, D. (2009). AAA phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer. British journal of cancer, 101(3), 550. DOI WoS1 |
| 2009 |
Olver, I. N., & Whitford, H. S. (2009). A randomized controlled trial of the effect of intercessory prayer on the spiritual wellbeing and quality of life of patients with cancer.. J Clin Oncol, 27(15_suppl), e20708. |
| 2009 |
Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gurney, H., . . . Australia and New Zealand Germ Cell Trials Group. (2009). Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: Updated analysis of a randomized trial with 8 years follow-up.. J Clin Oncol, 27(15_suppl), 5016. |
| 2009 |
Beckmann, K., Olver, I., Young, G., Roder, D., Foreman, L., & Wilson, B. (2009). Patient and carer perceptions of cancer care in South Australia. Australian Health Review, 33(4), 645-655. DOI Scopus3 WoS2 Europe PMC1 |
| 2009 |
Eliott, J., & Olver, I. (2009). Hope, Life, and Death: A Qualitative Analysis of Dying Cancer Patients' Talk About Hope. Death Studies, 33(7), 609-638. DOI Scopus92 WoS77 Europe PMC61 |
| 2009 |
Olver, I., Whitford, H., Denson, L., Peterson, M., & Olver, S. (2009). Improving informed consent to chemotherapy: A randomized controlled trial of written information versus an interactive multimedia CD-ROM. Patient Education and Counseling, 74(2), 197-204. DOI Scopus39 WoS38 Europe PMC32 |
| 2009 |
van Hazel, G. A., Pavlakis, N., Goldstein, D., Olver, I. N., Tapner, M. J., Price, D., . . . George, J. (2009). Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. Journal of clinical oncology, 27(25), 4089-4095. DOI Scopus128 WoS110 Europe PMC88 |
| 2009 |
Pawlik, T. M., Olver, I. N., Storm, C. D., & Rodriguez, C. (2009). Can physicians refuse treatment to patients who smoke?. Journal of oncology practice, 5(5), 250-251. DOI Scopus5 WoS5 |
| 2009 |
Olver, I. N., & Haines, I. E. (2009). What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century?. Medical journal of Australia, 190(2), 74-77. DOI Scopus11 WoS11 Europe PMC7 |
| 2009 |
Olver, I. N., & Haines, I. E. (2009). In reply. Medical Journal of Australia, 190(8), 461. DOI Scopus1 |
| 2009 |
Haines, I. E., & Olver, I. (2009). Are guidelines on use of colony-stimulating factors in solid cancers flawed?. Internal medicine journal, 39(4), 259-262. DOI Scopus6 WoS4 Europe PMC4 |
| 2009 |
Olver, I. (2009). Playing gene monopoly. Australian Life Scientist, 6(6), 14. |
| 2009 |
Olver, I. N., & Haines, I. E. (2009). What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century? <i>REPLY</i>. MEDICAL JOURNAL OF AUSTRALIA, 190(8), 461. DOI WoS1 |
| 2008 |
Olver, I. N., & Eliott, J. (2008). Patients' use of humour in discussing sensitive end-of-life issues. JOURNAL OF CLINICAL ONCOLOGY, 26(15), 1 page. DOI |
| 2008 |
Olver, I., & Eliott, J. (2008). The role of humour in communicating with patients about end-of-life issues. PSYCHO-ONCOLOGY, 17, S31-S32. |
| 2008 |
Shepherdley, C., Goldstein, S., Olver, I. N., & Parle, M. (2008). Enhancing psychosocial care for people with cancer in rural communities: What can remote counselling offer?. Australian health review, 32(3), 423-438. DOI Scopus27 WoS23 Europe PMC17 |
| 2008 |
Clayton, J. M., Hancock, C., Parker, R., Butow, P., Walder, S., Carrick, S., . . . Tattersall, M. H. N. (2008). Sustaining hope when communicating with terminally ill patients and their families: A systematic review. Psycho-Oncology, 17(7), 641-659. DOI Scopus263 WoS214 Europe PMC189 |
| 2008 |
Haines, T. P., & Olver, I. N. (2008). Are self-regulation and declaration of conflict of interest still the benchmark for relationships between physicians and industry?. Medical journal of Australia, 189(5), 263-266. DOI Scopus15 WoS17 Europe PMC9 |
| 2008 |
Olver, I. (2008). An informed choice. Australian Doctor, (28/MAR.), 20. |
| 2008 |
Olver, I. N., & Grogan, P. B. (2008). Cancer adds further urgency to prioritising obesity control. Medical journal of Australia, 189(4), 191-192. DOI |
| 2008 |
Olver, I. N. (2008). Prevention of chemotherapy-induced nausea and vomiting: Focus on fosaprepitant. Therapeutics and Clinical Risk Management, 4(2), 501-506. DOI Scopus11 Europe PMC6 |
| 2008 |
Olver, I. N. (2008). Trastuzumab as the laed monoclonal antibody in advanced breast cancer: Choosing which patient and when. Future Oncology, 4(1), 125-131. DOI Scopus7 WoS8 Europe PMC6 |
| 2008 |
Luckett, P., Butow, P., King, M., & Olver, I. N. (2008). Psycho-social issues in long-term survivors of testicular cancer: Directions for future research. Asia Pacific Journal of Clinical Oncology, 4(3), 125-131. DOI Scopus11 WoS9 |
| 2008 |
Whitford, H., Olver, I., & Peterson, M. (2008). Spirituality as a core domain in the assessment of quality of life in oncology. Psycho-Oncology, 17(11), 1121-1128. DOI Scopus131 WoS122 Europe PMC89 |
| 2008 |
Botten, R., Yeoh, E. K., Matteo, D. I. A., Butters, J., Dhillon, V., Holloway, R. H., . . . Fenech, M. (2008). Cytokinesis blocked micronucleus (CBMN) assay is predictive of gastrointestinal (GI) sequelae 2 years following radiation therapy (RT) for prostate carcinoma (CAP) while micronutrients reduce their severity. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23, A287. |
| 2008 |
Eliott, J., & Olver, I. (2008). Dying cancer patients talk about euthanasia. Social Science & Medicine, 67(4), 647-656. DOI Scopus27 WoS21 Europe PMC18 |
| 2008 |
Khan, O., Ranson, M., Michael, M., Olver, I., Levitt, N., Mortimer, P., . . . Middleton, M. (2008). A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer. British Journal of Cancer, 98(10), 1614-1618. DOI Scopus52 WoS50 Europe PMC40 |
| 2008 |
Olver, I., & Eliott, J. (2008). The perceptions of do-not-resuscitate policies of dying patients with cancer. Psycho-Oncology, 17(4), 347-353. DOI Scopus24 WoS24 Europe PMC23 |
| 2008 |
Eliott, J., & Olver, I. (2008). Choosing between life and death: Patient and family perceptions of the decision not to resuscitate the terminally ill cancer patient. Bioethics, 22(3), 179-189. DOI Scopus34 WoS32 Europe PMC26 |
| 2008 |
Eliott, J., Kealey, C., & Olver, I. (2008). (Using) complementary and alternative medicine: The perceptions of palliative patients with cancer. Journal of Palliative Medicine, 11(1), 58-67. DOI Scopus37 WoS25 Europe PMC19 |
| 2008 |
Koczwara, B., Ackland, S., Esterman, A. J., Marine, F., Stockler, M., & Olver, I. (2008). The impact of Australia Asia Pacific clinical oncology research development (ACORD) on research productivity of participants according to region of origin. Journal of clinical oncology, 25(18), 1. |
| 2008 |
Canepari, M., Vogt, K., & Zecevic, D. (2008). Combining Voltage and Calcium Imaging from Neuronal Dendrites. CELLULAR AND MOLECULAR NEUROBIOLOGY, 28(8), 1079-1093. DOI WoS44 Europe PMC35 |
| 2008 |
Cai, N., Storm, C. D., & Olver, I. N. (2008). Making the decision to not attempt resuscitation. Journal of Oncology Practice, 4(2), 99-100. DOI |
| 2007 |
Olver, I. (2007). Xerostomia comment. AUSTRALIAN PRESCRIBER, 30(1), 4. |
| 2007 |
Mayr, P., & Walter, A. -K. (2007). An exploratory study of Google Scholar. ONLINE INFORMATION REVIEW, 31(6), 814-830. DOI WoS69 |
| 2007 |
Olver, I. (2007). Xerostomia [3]. Australian Prescriber, 30(1), 4. |
| 2007 |
Olver, I., Shepherd, L., & Selva-Nayagam, S. (2007). Beyond the bush telegraph: Telehealth for remote cancer control and support. Cancer Forum, 31(2), 77-80. Scopus4 WoS5 |
| 2007 |
Luke, C., Gill, P., Birrell, S., Humeniuk, V., Borg, M., Karapetis, C., . . . Roder, D. (2007). Treatment and survival from breast cancer: The experience of patients at South Australian teaching hospitals between 1977 and 2003. Journal of Evaluation in Clinical Practice, 13(2), 212-220. DOI Scopus7 WoS7 Europe PMC6 |
| 2007 |
Joshi, R., Olver, I., Keefe, D., Marafioti, T., & Smith, K. (2007). A phase I study to assess the safety and activity of topical lovastatin (FP252S) for the prevention of chemotherapy-induced alopecia. Supportive Care in Cancer, 15(9), 1109-1112. DOI Scopus8 WoS5 Europe PMC4 |
| 2007 |
Eliott, J., & Olver, I. (2007). The Implications of Dying Cancer Patients' Talk on Cardiopulmonary Resuscitation and Do-Not-Resuscitate Orders. Qualitative Health Research, 17(4), 442-455. DOI Scopus24 WoS18 Europe PMC14 |
| 2007 |
Brown, M., Wilkinson, C., Rudzi, Z., & Olver, I. (2007). Why we will need to learn new skills to control cancer. Internal Medicine Journal, 37(3), 201-204. DOI Scopus4 WoS4 Europe PMC2 |
| 2007 |
Eliott, J., & Olver, I. (2007). Hope and hoping in the talk of dying cancer patients. Social Science & Medicine, 64(1), 138-149. DOI Scopus111 WoS97 Europe PMC67 |
| 2007 |
Borgas, M., Yeoh, E., Bochner, M., Butters, J., Van Doorn, T., Farshid, G., . . . Rush, G. (2007). Feasibility study on the MammoSite in early-stage breast cancer: initial experience. Australasian Radiology, 51(1), 53-61. DOI Scopus3 WoS4 Europe PMC3 |
| 2007 |
Eliott, J., & Olver, I. (2007). Autonomy and the family as (in) appropriate surrogates for DNR decisions: A qualitative analysis of dying cancer patients' talk. Journal of Clinical Ethics, 18(3), 206-218. DOI Scopus13 WoS7 Europe PMC6 |
| 2007 |
Eliott, J., & Olver, I. (2007). Response from Eliott and Olver. Journal of Clinical Ethics, 18(3), 233-234. DOI |
| 2007 |
Singhal, N., Brown, M., Brown, G., Hall, V., & Olver, I. (2007). Assessment of parameters of response to combined modality treatment of locally advanced breast cancer. BREAST, 16, S52. DOI |
| 2007 |
Olver, I. N. (2007). Challenges in cancer control in Australia. Medical Journal of Australia, 186(11), 556-557. DOI Scopus1 WoS1 Europe PMC1 |
| 2007 |
Clayton, J. M., Hancock, K. M., Butow, P. N., Tattersall, M. H. N., Currow, D. C., Adler, J., . . . Yates, P. (2007). Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers.. Medical Journal of Australia, 186(12 Suppl), S77-S83. DOI Scopus342 Europe PMC161 |
| 2007 |
Olver, I., Shelukar, S., & Thompson, K. C. (2007). Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2(1), 13-18. DOI WoS43 Europe PMC30 |
| 2007 |
Olver, I. N., Byrne, M. J., Walpole, E., Vorobiof, D., Jacobs, C., Maart, K., . . . Pinel, M. C. (2007). Phase II study of IV vinflunine in patients with chemotherapy naive metastatic malignant melanoma. European Journal of Cancer, 43(12), 1829-1832. DOI Scopus11 WoS11 Europe PMC10 |
| 2006 |
Olver, I. N. (2006). The development of future research strategies from reviewing antiemetic trials for chemotherapy induced emesis.. Reviews on Recent Clinical Trials, 1(1), 61-66. DOI Scopus6 WoS5 Europe PMC4 |
| 2006 |
Olver, I. N. (2006). Antiemetic research: Solving patient problems. Cancer Forum, 30(2), 123-126. |
| 2006 |
Eliott, J. A., & Olver, I. N. (2006). The patient in the family: A discursive analytic study of dying patients' (and their family's) talk on the do-not-resuscitate decision. PSYCHO-ONCOLOGY, 15(2), S233-S234. |
| 2006 |
Eliott, J., & Olver, I. (2006). Hoping is better than hope: A discursive analysis of dying cancer patients' talk. AUSTRALIAN JOURNAL OF PSYCHOLOGY, 58, 27. |
| 2006 |
Olver, I. N., & Eliott, J. A. (2006). The meanings of 'hope' to patients living and dying with cancer. PSYCHO-ONCOLOGY, 15(2), S352-S353. |
| 2006 |
Eliott, J. A., Kealey, C. P., & Olver, I. N. (2006). (Using) complementary and alternative medicine: A discourse analytic study of cancer patients' talk. PSYCHO-ONCOLOGY, 15(2), S117. |
| 2006 |
Sambrook, P., Olver, I., & Goss, A. (2006). Bisphosphonates and the osteonecrosis of the jaw. Australian Family Physician, 35(10), 801-803. Scopus75 Europe PMC48 |
| 2006 |
Olver, I. (2006). Caring for dying people of different faiths, 3rd edition. Psycho-Oncology, 15(5), 446-447. DOI |
| 2006 |
Pittman, K., Olver, I., Koczwara, B., Kotasek, D., Patterson, W., Keefe, D., . . . Price, T. (2006). Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study. British Journal of Cancer, 95(10), 1309-1313. DOI Scopus32 WoS30 Europe PMC26 |
| 2006 |
Millward, M., House, C., Bowtell, D., Webster, L., Olver, I., Gore, M., . . . Zalcberg, J. (2006). The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study. British Journal of Cancer, 95(7), 829-834. DOI Scopus55 WoS47 Europe PMC45 |
| 2006 |
Marcu, L., Bezak, E., & Olver, I. (2006). Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach. Physics in Medicine and Biology, 51(15), 3625-3639. DOI Scopus30 WoS27 Europe PMC25 |
| 2006 |
Goldstein, D., Ackland, S., Bell, D., Olver, I., Davis, I., Rosenthal, M., . . . Byrne, M. (2006). Phase II study of vinflunine in patients with metastatic renal cell carcinoma. Investigational New Drugs, 24(5), 429-434. DOI Scopus17 WoS14 Europe PMC16 |
| 2006 |
O'Brien, P., Roos, D., Pratt, G., Liew, K., Barton, M., Poulsen, M., . . . Trotter, G. (2006). Combined-modality therapy for primary central nervous system lymphoma: Long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group). International Journal of Radiation Oncology Biology Physics, 64(2), 408-413. DOI Scopus88 WoS70 Europe PMC61 |
| 2006 |
Marcu, L., & Olver, I. (2006). Tirapazamine: from bench to clinical trials. Current Clinical Pharmacology, 1(1), 71-79. DOI Scopus105 WoS102 Europe PMC79 |
| 2006 |
Roila, F., Aapro, M., Ballatori, E., Borjeson, S., Clark-Snow, R. A., Del Favero, A., . . . Warr, D. (2006). Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the 2004 Perugia International Antiemetic Consensus Conference. Annals of Oncology, 17(1), 20-28. DOI Scopus319 Europe PMC194 |
| 2006 |
Koczwara, B., Barton, M. B., Tattersall, M. H., Turner, D. R., Olver, I. N., & Starmer, D. L. (2006). How not to effect change in curricula [3]. Medical Journal of Australia, 185(1), 52. DOI Scopus3 WoS4 Europe PMC4 |
| 2006 |
Olver, I. N. (2006). Xerostomia: A common adverse effect of drugs and radiation. Australian Prescriber, 29(4), 97-98. DOI Scopus11 WoS4 |
| 2006 |
Hedayati, H., Whitford, H., & Olver, I. (2006). Improving the chemotherapy consent process: Longitudinal assessment of patient recall. PSYCHO-ONCOLOGY, 15(2), S263. |
| 2006 |
Olver, I., & Whitford, H. (2006). Improving informed consent to chemotherapy: Written information versus an interactive CD-ROM. PSYCHO-ONCOLOGY, 15(2), S353. |
| 2006 |
Whitford, H., Olver, I., & Peterson, M. (2006). Spirituality as a core domain in the assessment of quality of life in oncology: An Australian perspective. PSYCHO-ONCOLOGY, 15(2), S457-S458. |
| 2006 |
Lewis, C. R., Olver, I. N., Walpole, E., Shannon, C., Pavlakis, N., Dalley, D., . . . Lybrand, S. (2006). Outcomes and health status of patients undergoing usual care for highly emetogenic chemotherapy.. J Clin Oncol, 24(18_suppl), 18591. |
| 2006 |
Olver, I. N., & Eliott, J. A. (2006). The meanings of "hope" to patients with cancer, nearing the end of their lives.. J Clin Oncol, 24(18_suppl), 18567. |
| 2006 |
Di Matteo, A. C., Botten, R. J., Butters, J., Salisbury, C., Dhillon, V., Fenech, M., . . . Yeoh, E. K. (2006). The Cytokinesis Blocked Micronucleus (CBMN) assay correlates with acute anorectal dysfunction after radiation therapy for carcinoma of the prostate and may predict individual radiosensitivity. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21, A342. |
| 2006 |
Wang, X. D., Jin, Z. S., Pei, X. R., Yang, J. J., & Zhang, Z. J. (2006). A novel method to prepare potassium sodium titanate nanotubes. CHINESE CHEMICAL LETTERS, 17(9), 1275-1278. WoS4 |
| 2006 |
Olver, I. N. (2006). ANTIEMETIC RESEARCH: SOLVING PATIENT PROBLEMS. CANCER FORUM, 30(2), 122-126. |
| 2005 |
Cox, K. (2005). Achieving equal standards in medical student education: is a national exit examination the answer?. MEDICAL JOURNAL OF AUSTRALIA, 183(3), 167-168. DOI WoS1 Europe PMC1 |
| 2005 |
Kris, M. G., Hesketh, P. J., Herrstedt, J., Rittenberg, C., Einhorn, L. H., Grunberg, S., . . . Ballatori, E. (2005). Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy. Supportive Care in Cancer, 13(2), 85-96. DOI Scopus113 WoS82 Europe PMC72 |
| 2005 |
Burmeister, B., Smithers, B., Gebski, V., Fitzgerald, L., Simes, R., Devitt, P., . . . Denham, J. (2005). Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. The Lancet Oncology, 6(9), 659-668. DOI Scopus901 Europe PMC661 |
| 2005 |
Eliott, J., & Olver, I. (2005). End-of-life decision making is more than rational. Communication and Medicine, 2(1), 21-34. DOI Scopus13 Europe PMC12 |
| 2005 |
Feyer, P., Maranzano, E., Molassiotis, A., Clark-Snow, R., Roila, F., Warr, D., & Olver, I. (2005). Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines. Supportive Care in Cancer, 13(2), 122-128. DOI Scopus51 WoS41 Europe PMC33 |
| 2005 |
Roila, F., Feyer, P., Maranzano, E., Olver, I., Clark-Snow, R., Warr, D., & Molassiotis, A. (2005). Antiemetics in children receiving chemotherapy. Supportive Care in Cancer, 13(2), 129-131. DOI Scopus25 WoS21 Europe PMC18 |
| 2005 |
Aapro, M., Molassiotis, A., & Olver, I. (2005). Anticipatory nausea and vomiting. Supportive Care in Cancer, 13(2), 117-121. DOI Scopus106 WoS78 Europe PMC60 |
| 2005 |
Olver, I., Keefe, D., Myers, M., & Caruso, D. (2005). A phase I study of prolonged ambulatory infusion of ifosfamide with oral mesna. Chemotherapy, 51(2-3), 142-146. DOI Scopus3 WoS2 Europe PMC2 |
| 2005 |
Koczwara, B., Tattersall, M., Barton, M., Coventry, B., Dewar, J., Miller, J., . . . Stockler, M. (2005). Achieving equal standards in medical student education: is a national exit examination the answer?. Medical Journal of Australia, 182(5), 228-230. DOI Scopus17 WoS19 Europe PMC13 |
| 2005 |
Maranzano, E., Feyer, P., Molassiotis, A., Rossi, R., Clark-Snow, R., Olver, I., . . . Roila, F. (2005). Evidence-based recommendations for the use of antiemetics in radiotherapy. Radiotherapy and Oncology, 76(3), 227-233. DOI Scopus45 WoS30 Europe PMC26 |
| 2005 |
Olver, I. (2005). Update on anti-emetics for chemotherapy-induced emesis. Internal Medicine Journal, 35(8), 478-481. DOI Scopus21 WoS18 Europe PMC15 |
| 2005 |
Luke, C., Koczwara, B., Moore, J., Olver, I., Penniment, M., Pittman, K., . . . Roder, D. (2005). Treatment and survival from colorectal cancer: The experience of patients at South Australian teaching hospitals between 1980 and 2002. Clinical Oncology, 17(5), 372-381. DOI Scopus14 WoS12 Europe PMC10 |
| 2005 |
Olver, I., Keefe, D., & Myers, M. (2005). Phase II study of prolonged ambulatory infusion carboplatin and oral etoposide for patients progressing through hormonal therapy for prostate cancer. Internal Medicine Journal, 35(7), 405-408. DOI Scopus6 WoS5 Europe PMC6 |
| 2005 |
Seshadri, T., Prince, H., Bell, D., Coughlin, P., James, P., Richardson, G., . . . Stewart, J. (2005). The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer. Medical Journal of Australia, 182(9), 453-457. DOI Scopus29 WoS21 Europe PMC19 |
| 2005 |
Kris, M., Hesketh, P., Herrstedt, J., Rittenberg, C., Einhorn, L., Grunberg, S., . . . Ballatori, E. (2005). Erratum: Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy. Supportive Care in Cancer, 13(7), 562. DOI |
| 2005 |
Marcu, L., Bezak, E., Olver, I., & Van Doorn, T. (2005). Tumour resistance to cisplatin: a modelling approach. Physics in Medicine and Biology, 50(1), 93-102. DOI Scopus21 WoS20 Europe PMC15 |
| 2005 |
Olver, I., Taylor, A., & Whitford, H. (2005). Relationships between patients' pretreatment expectations of toxicities and post chemotherapy experiences. Psycho-Oncology, 14(1), 25-33. DOI Scopus31 WoS28 Europe PMC27 |
| 2005 |
Koczwara, B., Barton, M., Coventry, B., Millar, J., Olver, I., Schwarz, M., & Schwarz, M. (2005). Cancer curriculum in the Asia-Pacific: opportunities and challenges in the age of globalization. Asia Pacific Journal of Clinical Oncology, 1(4), 109-113. DOI |
| 2005 |
Roila, F., Feyer, P., Maranzano, E., Olver, I., Clark-Snow, R., Warr, D., & Molassiotis, A. (2005). Erratum: Antiemetics in children receiving chemotherapy: (Supportive Care in Cancer (2004) DOI: 10.1007/s00520-004-0702-6). Supportive Care in Cancer, 13(2), 132. DOI |
| 2005 |
Olver, I., Brooksbank, M., Champion, N., & Keeley, J. (2005). The use of videophones to enhance palliative care outreach nursing in remote areas. Progress in Palliative Care, 13(5), 263-266. DOI Scopus16 WoS16 |
| 2004 |
Olver, I. (2004). Two decades of progress in treating chemotherapy induced emesis. Cancer Forum, 28(3), 140-143. Scopus2 |
| 2004 |
Marcu, L., Van Doorn, T., & Olver, I. (2004). Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas. Physics in Medicine and Biology, 49(16), 3767-3779. DOI Scopus36 WoS34 Europe PMC31 |
| 2004 |
Wakefield, M., Olver, I., Whitford, H., & Rosenfeld, E. (2004). Motivational interviewing as a smoking cessation intervention for patients with cancer: Randomized controlled trial. Nursing Research, 53(6), 396-405. DOI Scopus78 WoS74 Europe PMC59 |
| 2004 |
Yap, Y., Coleman, M., & Olver, I. (2004). Aggressive mixed epithelial-stromal tumour of the kidney treated with chemotherapy and radiotherapy. The Lancet Oncology, 5(12), 747-749. DOI Scopus49 WoS44 Europe PMC39 |
| 2004 |
Olver, I. (2004). Aprepitant in antiemetic combinations to prevent chemotherapy-induced nausea and vomiting. International Journal of Clinical Practice, 58(2), 201-206. DOI Scopus14 WoS11 Europe PMC9 |
| 2004 |
Schofield, P., Ball, D., Smith, J., Borland, R., O'Brien, P., Davis, S., . . . Joseph, D. (2004). Optimism and survival in lung carcinoma patients. Cancer, 100(6), 1276-1282. DOI Scopus66 WoS45 Europe PMC33 |
| 2003 |
Eliott, J., & Olver, I. (2003). Perceptions of "good palliative care" orders: A discursive study of cancer patients' comments. Journal of Palliative Care, 6(1), 59-68. DOI Scopus6 Europe PMC2 |
| 2003 |
Eliott, J., & Olver, I. (2003). Legitimating do-not-resuscitate orders: A discursive study of cancer patients' speech. Journal of Palliative Care, 19(2), 100-106. DOI Scopus7 WoS7 Europe PMC4 |
| 2003 |
Doyle, J., Brinkworth, C., Wegener, K., Carver, J., Llewellyn, L., Olver, I., . . . Tyler, M. (2003). nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications. FEBS Journal, 270(6), 1141-1153. DOI Scopus80 WoS70 Europe PMC55 |
| 2003 |
Marcu, L., Van Doorn, T., & Olver, I. (2003). Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer - a review of their cooperation. Acta Oncologica, 42(4), 315-325. DOI Scopus60 WoS53 Europe PMC47 |
| 2003 |
Liebert, B., Parle, M., Roberts, C., Redman, S., Carrick, S., Gallagher, J., . . . Trotter, J. (2003). An evidence-based specialist breast nurse role in practice: a multicentre implementation study. EUROPEAN JOURNAL OF CANCER CARE, 12(1), 91-97. DOI WoS23 Europe PMC20 |
| 2003 |
Olver, I. (2003). Telemedicine in oncology.. Current Problems in Dermatology, 32, 121-126. DOI Scopus4 Europe PMC3 |
| 2002 |
Marcu, L., Van Doorn, T., Zavgorodni, S., & Olver, I. (2002). Growth of a virtual tumour using probabilistic methods of cell generation. Australasian Physical and Engineering Sciences in Medicine, 25(4), 155-161. DOI Scopus21 Europe PMC19 |
| 2002 |
Healey, T., Olver, I., & Selva-Nayagam, S. (2002). Immunoproliferative small intestinal disease, two cases in the Northern Territory. Internal Medicine Journal, 32(1-2), 47-49. DOI Scopus3 WoS3 Europe PMC2 |
| 2002 |
Borbasi, S., Cameron, K., Quested, B., Olver, I., To, L., & Evans, D. (2002). More than a sore mouth: Patients' experience of oral mucositis. Oncology Nursing Forum, 29(7), 1051-1057. DOI Scopus56 Europe PMC54 |
| 2002 |
Eliott, J., & Olver, I. (2002). The discursive properties of "hope": A qualitative analysis of cancer patients' speech. Qualitative Health Research, 12(2), 173-193. DOI Scopus117 WoS91 Europe PMC74 |
| 2002 |
Olver, I., Eliott, J., & Mortimer, J. (2002). Cancer patients' perceptions of do not resuscitate orders. Psycho-Oncology, 11(3), 181-187. DOI Scopus17 WoS14 Europe PMC12 |
| 2002 |
Olver, I., Hercus, T., Lopez, A., Vadas, M., Somogyi, A., Doyle, I., . . . Wigley, P. (2002). A phase I study of the GM-CSF antagonist E21R. Cancer Chemotherapy and Pharmacology, 50(3), 171-178. DOI Scopus8 WoS8 Europe PMC7 |
| 2002 |
Eliott, J., & Olver, I. (2002). Legitimating do-not-resuscitate orders: A qualitative study of cancer patients' talk. AUSTRALIAN JOURNAL OF PSYCHOLOGY, 54(2), 116. |
| 2002 |
Castiglione-Gertsch, M., Price, K. N., Goldhirsch, A., Coates, A. S., Colleoni, M., Nasi, M. L., . . . Fey, M. F. (2002). Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trial. Journal of the National Cancer Institute, 94(14), 1054-1065. DOI Scopus150 WoS131 Europe PMC97 |
| 2001 |
Roberts, A. W., Gunawardana, D., Rosenthal, M. A., Green, M., Basser, R. L., Davis, I. D., . . . Ashley, D. (2001). Phase I study of the effects of progenipoietin (SD-9427) on hematopoiesis.. BLOOD, 98(11), 299A. WoS1 |
| 2001 |
Ahrens, C., Denson, L., Moar, K., & Olver, I. N. (2001). Written informed consent: Patient comprehension and contributing factors. AUSTRALIAN JOURNAL OF PSYCHOLOGY, 53, 136. |
| 2001 |
Olver, I. (2001). Telemedicine: prospects and realities. Medicine Today, 2(1), 81-84. |
| 2001 |
Boyer, M., Mitchell, P., Goldstein, D., Millward, M., Olver, I., Clarke, S., . . . Davis, I. (2001). Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer. Lung Cancer, 32(1), 89-94. DOI Scopus4 WoS4 Europe PMC2 |
| 2001 |
Toner, G., Stockler, M., Boyer, M., Jones, M., Thomson, B., Harvey, V., . . . Simes, R. (2001). Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Lancet, 357(9258), 739-745. DOI Scopus106 WoS80 Europe PMC69 |
| 2001 |
Olver, I., Davy, M., Luftner, D., Park, S., Egorin, M., Ellis, A., & Webster, L. (2001). A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer. Cancer Chemotherapy and Pharmacology, 48(2), 109-114. DOI Scopus4 WoS5 Europe PMC2 |
| 2000 |
Olver, I. (2000). Guest Editorial - Nausea and Vomiting. Current Therapeutics, November 2, 7-9. |
| 2000 |
Olver, I., & Selva-Nayagam, R. (2000). Evaluation of a telemedicine link between Darwin and Adelaide to facilitate cancer management. Telemedicine Journal and E-health, 6(2), 213-218. DOI Scopus69 WoS60 Europe PMC45 |
| 2000 |
Parnis, F., Olver, I., Kotasek, D., Norman, J., Taylor, A., Russell, J., . . . Marafioti, T. (2000). Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site. Annals of Oncology, 11(7), 883-884. DOI Scopus17 WoS16 Europe PMC14 |
| 2000 |
Olver, I. (2000). Chemotherapy for elderly patients with advanced cancer: is it worth it?. Australian Prescriber, 23(4), 80-82. DOI Scopus8 |
| 2000 |
Olver, I., Stephenson, J., & Schulze, D. (2000). A phase I study of prolonged ambulatory infusion carboplatin with oral etoposide showing activity in prostate cancer. Cancer Chemotherapy and Pharmacology, 46(4), 338-341. DOI Scopus4 WoS4 Europe PMC3 |
| 2000 |
O'Brien, P., Roos, D., Pratt, G., Liew, K., Barton, M., Poulsen, M., . . . Trotter, G. (2000). Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. Journal of Clinical Oncology, 18(3), 519-526. DOI Scopus218 WoS170 Europe PMC143 |
| 2000 |
Webster, L., Olver, I., Stokes, K., Sephton, R., Hillcoat, B., & Bishop, J. (2000). A pharmacokinetic and phase II study of gallium nitrate in patients with non-small cell lung cancer. Cancer Chemotherapy and Pharmacology, 45(1), 55-58. DOI Scopus18 WoS12 Europe PMC6 |
| 2000 |
Rozek, T., Wegener, K., Bowie, J., Olver, I., Carver, J., Wallace, J., & Tyler, M. (2000). The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis: The solution structure of aurein 1.2. FEBS Journal, 267(17), 5330-5341. DOI Scopus278 WoS257 Europe PMC193 |
| 2000 |
Olver, I., Wakefield, M., & Roberts, L. (2000). Community beliefs about cancer treatment and care in South Australia. Cancer Forum, 24(1), 18-19. Scopus3 |
| 2000 |
Clarke, S. J., Zalcberg, J., Olver, I., Mitchell, P. L. R., Rischin, D., Dalley, D., . . . Davidson, Y. E. (2000). Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neck. Annals of Oncology, 11(2), 239-241. DOI Scopus12 WoS8 Europe PMC6 |
| 2000 |
Olver, I. N., & Eliott, J. (2000). Autonomy and end-of-life decision-making. PSYCHO-ONCOLOGY, 9(5), S37. WoS1 |
| 2000 |
Wigley, P., Olver, I., Bardy, P., Donadieu, J., Lopez, A., Bastiras, S., . . . Verma, M. (2000). E21R: A GM-CSF analogue with potential as an anti-cancer agent.. CLINICAL CANCER RESEARCH, 6, 4559S. |
| 2000 |
Ahrens, C., Densen, L., Moar, K., & Olver, I. (2000). Patient understanding of written consent to chemotherapy. PSYCHO-ONCOLOGY, 9(5), S73. |
| 2000 |
Von Pawel, J., Von Roemeling, R., Gatzemeier, U., Boyer, M., Elisson, L. O., Clark, P., . . . Treat, J. (2000). Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Journal of Clinical Oncology, 18(6), 1351-1359. DOI Scopus280 WoS241 Europe PMC172 |
| 1999 |
Taylor, A., Olver, I., Sivanthan, T., Chi, M., & Purnell, C. (1999). Observer error in grading performance status in cancer patients. European Journal of Cancer, 35(Suppl. 4), S363-S364. DOI |
| 1999 |
Castagnola, E., Viscoli, C., Olver, I. N., Price, T. J., & Patterson, W. K. (1999). Rifampicin as treatment for pruritus in malignant cholestasis: An example of an improper indication for anti-infective drugs (multiple letters). Supportive Care in Cancer, 7(3), 160. Scopus2 Europe PMC1 |
| 1999 |
Kollias, J., Olver, I. N., Kissane, D. W., Clarke, D. M., Ikin, J., Bloch, S., . . . McKenzie, D. P. (1999). Psychological morbidity and quality of life in Australian women with early-stage breast cancer: A cross-sectional survey (multiple letters) [6]. Medical Journal of Australia, 170(5), 239-240. DOI Scopus1 |
| 1999 |
Tattersall, M., & Olver, I. (1999). Conflict of interests and advisory committees. International Journal of Pharmaceutical Medicine, 13(6), 325-328. Scopus1 |
| 1999 |
Olver, I. (1999). A mass of exam nerves. Current Therapeutics, 40(8), 44-46. |
| 1999 |
Olver, I. (1999). Management of prostate cancer. Current Therapeutics, 40(7), 73-82. |
| 1999 |
Ball, D., Bishop, J., Smith, J., O'Brien, P., Davis, S., Ryan, G., . . . Joseph, D. (1999). A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: Final report of an Australian multi-centre trial. Radiotherapy and Oncology, 52(2), 129-136. DOI Scopus137 WoS121 Europe PMC94 |
| 1999 |
Bishop, J. F., Dewar, J., Toner, G. C., Smith, J., Tattersall, M. H. N., Olver, I. N., . . . Canetta, R. (1999). Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. Journal of Clinical Oncology, 17(8), 2355-2364. DOI Scopus200 WoS163 Europe PMC119 |
| 1999 |
Adams, W., Cartmill, J., Chapuis, P., Cunningham, I., Farmer, K. C., Hewett, P., . . . Waxman, B. (1999). Practice parameters for the management of colonic cancer II: Other issues. Recommendations of the Colorectal Surgical Society of Australia. Australian and New Zealand Journal of Surgery, 69(7), 472-478. DOI WoS5 |
| 1999 |
Moore, J., Hewett, P., Penfold, J. C., Adams, W., Cartmill, J., Chapuis, P., . . . Waxman, B. (1999). Practice parameters for the management of colonic cancer I: Surgical issues. Recommendations of the colorectal surgical society of Australia. Australian and New Zealand Journal of Surgery, 69(6), 415-421. DOI Scopus7 WoS3 Europe PMC4 |
| 1999 |
Basser, R., To, L., Collins, J., Begley, C., Keefe, D., Cebon, J., . . . Green, M. (1999). Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage ii or iii breast cancer: five-year follow-up. Journal of Clinical Oncology, 17(1), 82-92. DOI Scopus20 WoS17 Europe PMC13 |
| 1999 |
Taylor, A. E., Olver, I. N., Sivanthan, T., Chi, M., & Purnell, C. (1999). Observer error in grading performance status in cancer patients. Supportive Care in Cancer, 7(5), 332-335. DOI Scopus126 WoS109 Europe PMC104 |
| 1998 |
Basser, R., To, L., Begley, C., Maher, D., Juttner, C., Cebon, J., . . . Green, M. (1998). Rapid hematopoietic recovery after multicycle high-dose chemotherapy; enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor. Journal of Clinical Oncology, 16(5), 1899-1908. DOI WoS28 Europe PMC19 |
| 1998 |
Price, T. J., Patterson, W. K., & Olver, I. N. (1998). Rifampicin as treatment for pruritus in malignant cholestasis. Supportive Care in Cancer, 6(6), 533-535. DOI Scopus19 WoS19 Europe PMC11 |
| 1998 |
Millward, M. J., Webster, L. K., Rischin, D., Stokes, K. H., Toner, G. C., Bishop, J. F., . . . Woodcock, D. M. (1998). Phase I trial of cremophor EL with bolus doxorubicin. Clinical Cancer Research, 4(10), 2321-2329. Scopus42 WoS35 Europe PMC26 |
| 1998 |
Olver, I. N., Green, M., Millward, M. J., & Bishop, J. F. (1998). Phase II study of acivicin in patients with recurrent high grade astrocytoma. Journal of Clinical Neuroscience, 5(1), 46-48. DOI Scopus14 WoS12 Europe PMC12 |
| 1998 |
Borg, M. F., Olver, I. N., & Hill, M. P. (1998). Rothmund-Thomson syndrome and tolerance of chemoradiotherapy. Australasian Radiology, 42(3), 216-218. DOI Scopus19 Europe PMC11 |
| 1998 |
Kissane, D. W., Clarke, D. M., Ikin, J., Bloch, S., Smith, G. C., Vitetta, L., & McKenzie, D. P. (1998). Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. MEDICAL JOURNAL OF AUSTRALIA, 169(4), 192-196. DOI WoS178 Europe PMC133 |
| 1998 |
Roila, F., Del Favero, A., Gralla, R. J., Tonato, M., Aapro, M. S., Andrews, P. L. R., . . . Stewart, A. (1998). Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus Conference. ANNALS OF ONCOLOGY, 9(8), 811-819. DOI WoS160 Europe PMC52 |
| 1998 |
Olver, I., Davy, M., Webster, L., Egorin, M., Luftner, D., & Park, S. H. (1998). A phase I trial with pharmacokinetics of paclitaxel and altretamine for ovarian cancer relapsing following cisplatin. ANNALS OF ONCOLOGY, 9, 68. WoS1 |
| 1997 |
Michael, M., Bishop, J. F., Levi, J. A., Bell, D. R., Zalcberg, J. R., Friedlander, M. L., . . . Toner, G. C. (1997). Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy. Medical Journal of Australia, 166(10), 520-523. DOI Scopus11 WoS10 Europe PMC3 |
| 1997 |
Bishop, J. F., Dewar, J., Toner, G., Tattersall, M. H., Olver, I., Ackland, S., . . . Stephenson, J. (1997). A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results. SEMINARS IN ONCOLOGY, 24(5), 5-9. WoS5 |
| 1997 |
Olver, I., Paska, W., Depierre, A., Seitz, J. F., Stewart, D. J., Goedhals, L., . . . Wilkinson, J. R. (1997). The control of delayed nausea - Response. ANNALS OF ONCOLOGY, 8(6), 615-616. DOI |
| 1997 |
Beller, E., Tattersall, M., Lumley, T., Levi, J., Dalley, D., Olver, I., . . . Simes, R. J. (1997). Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial. Annals of Oncology, 8(3), 277-283. DOI Scopus79 WoS67 |
| 1997 |
Cunningham, D., Zalcberg, J. R., Rath, U., Oliver, I., Van Cutsem, E., Svensson, C., . . . Perez-Manga, G. (1997). Erratum: Final results of a randomised trial comparing 'Tomudex'® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. (Ann Oncol (1996) 7 (9) (961-965)). Annals of Oncology, 8(4), 407. DOI Scopus1 |
| 1997 |
Bishop, J. F., Dewar, J., Toner, G., Tattersall, M. H., Olver, I., Ackland, S., . . . Stephenson, J. (1997). A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.. Seminars in oncology, 24(5 Suppl 17), S17-5-S17-9. Europe PMC3 |
| 1997 |
Michael, M., Toner, G. C., Olver, I. N., Fenessy, A., & Bishop, J. F. (1997). Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancer. American Journal of Clinical Oncology Cancer Clinical Trials, 20(3), 259-262. DOI Scopus1 WoS2 Europe PMC1 |
| 1997 |
Boyer, M. J., Zalcberg, J., Olver, I. N., Millward, M. J., Richardson, G., & McKeage, M. J. (1997). Phase I study of paclitaxel and oral etoposide in previously uutreated non-small-cell and extensive small-cell lung cancer. Annals of Oncology, 8(5), 485-489. DOI Scopus7 WoS7 Europe PMC4 |
| 1997 |
Bishop, J. F., Dewar, J., Toner, G. C., Tattersall, M. H., Olver, I. N., Ackland, S., . . . Stephenson, J. (1997). Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand.. Oncology (Williston Park, N.Y.), 11(4 Suppl 3), 19-23. Europe PMC17 |
| 1997 |
Beller, E., Tattersall, M., Lumley, T., Levi, J., Dalley, D., Olver, I., . . . Simes, R. J. (1997). Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.. Annals of oncology : official journal of the European Society for Medical Oncology, 8(3), 277-283. DOI Europe PMC60 |
| 1997 |
Joschko, M. A., Webster, L. K., Bishop, J. F., Groves, J., Yuen, K., Olver, I. N., . . . Ball, D. L. (1997). Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft. Cancer Chemotherapy and Pharmacology, 40(6), 534-539. DOI Scopus14 WoS14 Europe PMC11 |
| 1997 |
Ball, D., Smith, J., Bishop, J., Olver, I., Davis, S., O'Brien, P., . . . Millward, M. (1997). A phase III study of radiotherapy with and without continuous-infusion fluorouracil as palliation for non-small-cell lung cancer. British Journal of Cancer, 75(5), 690-697. DOI Scopus55 WoS44 Europe PMC32 |
| 1997 |
Parnis, F., Olver, I., Sandeman, T., Bishop, J., & Laidlaw, C. (1997). A phase II trial of cisplatin and interferon alpha 2b in patients with advanced bladder cancer.. American Journal of Clinical Oncology CCT, 20(3), 319-321. DOI Scopus4 WoS4 Europe PMC2 |
| 1996 |
O'Brien, P., Roos, D., Liew, K., Trotter, G., Barton, M., Walker, Q., . . . Olver, I. (1996). Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Medical Journal of Australia, 165(8), 424-427. DOI Scopus20 WoS18 Europe PMC7 |
| 1996 |
Olver, I., Paska, W., Depierre, A., Seitz, J. F., Stewart, D. J., Goedhals, L., . . . Wilkinson, J. R. (1996). A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study Group.. Annals of oncology : official journal of the European Society for Medical Oncology, 7(9), 945-952. DOI Europe PMC44 |
| 1996 |
Olver, I. N. (1996). Antiemetic Study Methodology: Recommendations for Future Studies. Oncology Switzerland, 53(1), 96-101. DOI Scopus16 WoS14 Europe PMC12 |
| 1996 |
Olver, I. N., Craft, P. S., Clingan, P. R., Kearsley, J. H., Planner, R. S., Van Hazel, G. A., . . . Pearson, L. L. (1996). An open multicentre study of tropisetron for cisplatin-induced nausea and vomiting. Medical Journal of Australia, 164(6), 337-340. DOI Scopus5 WoS4 Europe PMC1 |
| 1996 |
Olver, I. N., Hughes, P. G., Smith, J. G., Narayan, K., & Bishop, J. F. (1996). Concurrent radiotherapy and continuous ambulatory infusion 5-fluorouracil in advanced head and neck cancer. European Journal of Cancer, 32(2), 249-254. DOI Scopus15 WoS12 Europe PMC13 |
| 1996 |
Millward, M. J., Bishop, J. F., Friedlander, M., Levi, J. A., Goldstein, D., Olver, I. N., . . . Bell, D. R. (1996). Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology, 14(1), 142-148. DOI Scopus70 WoS78 Europe PMC43 |
| 1996 |
Olver, I., Paska, W., Depierre, A., Seitz, J. F., Stewart, D. J., Goedhals, L., . . . Wilkinson, J. R. (1996). A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Annals of Oncology, 7(9), 945-952. DOI Scopus69 WoS53 |
| 1996 |
Cunningham, D., Zalcberg, J. R., Rath, U., Oliver, I., Van Cutsem, E., Svensson, C., . . . Perez-Manga, G. (1996). Final results of a randomised trial comparing 'Tomudex'® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Annals of Oncology, 7(9), 961-965. DOI Scopus244 Europe PMC125 |
| 1996 |
Cunningham, D., Zalcberg, J. R., Rath, U., Olver, I., Van Cutsem, E., Svensson, C., . . . Lowery, K. (1996). 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. European Journal of Cancer Part A, 32(SUPPL. 5), 1945-1954. DOI Scopus17 |
| 1996 |
Cunningham, D., Zalcberg, J. R., Rath, U., Olver, I., VanCutsem, E., Svensson, C., . . . Lowery, K. (1996). 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia (Reprinted from European Journal of Cancer, vol 32A, pg 1945-1954, 1995). EUROPEAN JOURNAL OF CANCER, 32A, R1-+. |
| 1995 |
Olver, I. N. (1995). An open label study of tropisetron for acute and delayed cisplatin-induced emesis. EUROPEAN JOURNAL OF CANCER, 31A, 1224. |
| 1995 |
Zalcberq, J., Cunningham, D., Rath, U., Olver, I., Kerr, D., VanCutsem, E., . . . Harper, P. (1995). 'Tomudex' (ZD1694) has a higher response rate, significantly less leucopenia and mucositis and a simpler dosing regimen than 5-fluorouracil (5-FU) and leucovorin (LV) for advanced colorectal cancer (CRC): First results of a phase III study. EUROPEAN JOURNAL OF CANCER, 31A, 701. |
| 1995 |
Phillips, K. A., Fitzharris, B., Friedlander, M., McCrystal, M., Olver, I., Joughin, J., . . . Smith, J. (1995). Australasian multicentre phase II study of paclitaxel (Taxol) in relapsed ovarian cancer. Australian and New Zealand Journal of Medicine, 25(4), 337-343. DOI Scopus15 WoS14 Europe PMC7 |
| 1995 |
Cunningham, D., Zalcberg, J. R., Rath, U., Olver, I., Van Cutsem, E., Svensson, C., . . . Lowery, K. (1995). 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. European Journal of Cancer, 31(12), 1945-1954. DOI Scopus137 WoS141 Europe PMC75 |
| 1995 |
Olver, I. N., Buchanan, L., Laidlaw, C., & Poulton, G. (1995). The adequacy of consent forms for informing patients entering oncological clinical trials. Annals of Oncology, 6(9), 867-870. DOI Scopus48 Europe PMC33 |
| 1995 |
Olver, I. N. (1995). Assessing the comparative clinical value of tropisetron. Australian and New Zealand Journal of Medicine, 25(5), 523-527. DOI Scopus1 WoS1 Europe PMC1 |
| 1995 |
Olver, I., Green, M., Peters, W., Zimet, A., Toner, G., Bishop, J., . . . Birkhofer, M. (1995). A phase II trial of zeniplatin in metastatic melanoma. American Journal of Clinical Oncology Cancer Clinical Trials, 18(1), 56-58. DOI Scopus10 WoS8 Europe PMC6 |
| 1995 |
Olver, I. N., Webster, L. K., Millward, M. J., Stokes, K. H., & Bishop, J. F. (1995). A phase I and pharmacokinetics study of prolonged ambulatory-infusion carboplatin. Cancer Chemotherapy and Pharmacology, 37(1-2), 79-85. DOI Scopus14 WoS14 Europe PMC7 |
| 1995 |
Olver, I. N., Turrell, S. J., Olszewski, N. A., & Willson, K. J. (1995). Impact of an information and consent form on patients having chemotherapy. Medical Journal of Australia, 162(2), 82-83. DOI Scopus39 WoS32 Europe PMC29 |
| 1995 |
Basser, R., To, L., Begley, C., Juttner, C., Maher, D., Szer, J., . . . Green, M. (1995). Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells. Clinical Cancer Research, 1(7), 715-721. Scopus38 WoS36 Europe PMC17 |
| 1994 |
Maher, D. W., Lieschke, G. J., Green, M., Bishop, J., Stuart-Harris, R., Wolf, M., . . . Morstyn, G. (1994). Filgrastim in patients with chemotherapy-induced febrile neutropenia: A double-blind, placebo-controlled trial. Annals of Internal Medicine, 121(7), 492-501. DOI Scopus219 WoS173 Europe PMC117 |
| 1994 |
Bishop, J. F., Ball, D., Crennan, E., Ryan, G., Davis, S., Toner, G., . . . Olver, I. (1994). Radiation and carboplatin combined-modality therapy in non-small cell lung cancer.. Seminars in oncology, 21(3 Suppl 6), 91-96. Europe PMC4 |
| 1994 |
Olver, I. N., Laidlaw, C. R., Matthews, J. P., Bishop, J. F., Hayes, A. M., Wolf, M., & Toner, G. C. (1994). A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapy. European Journal of Cancer, 30(4), 426-429. DOI Scopus6 WoS4 Europe PMC2 |
| 1994 |
Olver, I. N., Matthews, J. P., Bishop, J. F., & Smith, R. A. (1994). The roles of patient and observer assessments in anti-emetic trials. European Journal of Cancer, 30(9), 1223-1227. DOI Scopus15 WoS13 Europe PMC7 |
| 1994 |
OLVER, I. N. (1994). CONFRONTATIONS WITH THE REAPER - FELDMAN,F. BIOETHICS, 8(3), 279-281. |
| 1994 |
Bishop, J., Ball, D., Crennan, E., Ryan, G., Davis, S., Toner, G., . . . Olver, I. (1994). Radiation and carboplatin combined-modality therapy in non-small cell lung cancer. Seminars in Oncology, 21(3 SUPPL. 6), 91-96. Scopus7 |
| 1993 |
Olver, I. N., Sandeman, T. F., Laidlaw, C. R., Zimet, A. S., & Bishop, J. F. (1993). Oral methotrexate for superficial transitional cell carcinoma of the bladder. Journal of Urology, 149(5), 1006-1009. DOI Scopus2 WoS1 Europe PMC1 |
| 1993 |
Thomson, D. B., Adena, M., McLeod, G. R. C., Hersey, P., Gill, P. G., Coates, A. S., . . . Kingston, D. (1993). Interferon-α2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: Results of a multi-institutional Australian randomized trial. Melanoma Research, 3(2), 133-138. Scopus133 WoS114 Europe PMC75 |
| 1993 |
Bishop, J. F., Smith, J. G., Jeal, P. N., Murray, R., Drummond, R. M., Pitt, P., . . . Bhowal, A. K. (1993). The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: A randomised double-blind placebo controlled trial. European Journal of Cancer, 29(6), 814-818. DOI Scopus9 WoS8 Europe PMC5 |
| 1993 |
Coates, A., Thomson, D., McLeod, G. R. M., Hersey, P., Gill, P. G., Olver, I. N., . . . Walpole, E. (1993). Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. European Journal of Cancer, 29(12), 1731-1734. DOI Scopus147 WoS131 Europe PMC102 |
| 1992 |
Olver, I. N. (1992). Antiemetic study design: desirable objectives, stratifications and analyses.. British Journal of Cancer Supplement, 19, S30-S33. Scopus1 WoS12 Europe PMC3 |
| 1992 |
Olver, I. N., Bishop, J. F., Green, M., Zimet, A., & Laidlaw, C. (1992). A phase II study of cisplatinum and continuous infusion 5-fluorouracil for metastatic melanoma. American Journal of Clinical Oncology Cancer Clinical Trials, 15(6), 503-505. DOI Scopus2 WoS2 Europe PMC1 |
| 1992 |
Rischin, D., Bishop, J. F., Olver, I. N., Laidlaw, C. R., Zimet, A., Jeal, P., & Dipell, J. F. (1992). A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer. American Journal of Clinical Oncology Cancer Clinical Trials, 15(5), 392-394. |
| 1992 |
Doig, R. G., Olver, I. N., Jeal, P. N., & Bishop, J. F. (1992). Symptomatic choroidal metastases in breast cancer. Australian and New Zealand Journal of Medicine, 22(4), 349-352. DOI Scopus6 WoS7 Europe PMC6 |
| 1992 |
Olver, I. N., Webster, L. K., Bishop, J. F., & Stokes, K. H. (1992). A phase I and pharmacokinetic study of 12-h infusion of flavone acetic acid. Cancer Chemotherapy and Pharmacology, 29(5), 354-360. DOI Scopus10 WoS13 Europe PMC7 |
| 1992 |
Olver, I. N. (1992). Methodology in anti-emetic trials. Oncology Switzerland, 49(4), 269-272. DOI Scopus8 WoS6 Europe PMC3 |
| 1992 |
Olver, I. N., Wolf, M., Laidlaw, C., Bishop, J. F., Cooper, I. A., Matthews, J., . . . Buchanan, L. (1992). A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy. European Journal of Cancer, 28(11), 1798-1802. DOI Scopus26 WoS21 Europe PMC14 |
| 1992 |
Bishop, J., Murray, R., Webster, L., Pitt, P., Stokes, K., Fennessy, A., . . . Leber, G. (1992). Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer. Cancer Chemotherapy and Pharmacology, 30(3), 174-178. DOI Scopus26 WoS22 Europe PMC17 |
| 1992 |
Bishop, J. F., Matthews, J. P., Wolf, M. M., Oliver, I. N., Reynolds, S., Walpole, E., . . . Tan, L. G. (1992). A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy. European Journal of Cancer, 28(1), 47-50. DOI Scopus7 Europe PMC7 |
| 1992 |
Morrow, G. R., Cull, A., Grunberg, S., Smyth, J., Tyers, M. B., Gralla, R. J., . . . Olver, I. N. (1992). Behavioural factors influencing the development and expression of chemotherapy induced side effects. British Journal of Cancer, 66(SUPPL. 19), S54-S63. Scopus32 Europe PMC8 |
| 1992 |
ROILA., SMYTH, J., BROWN., KOSLOW, W., TYERS., JURGENS., . . . AYA. (1992). ONDANSETRON - A NEW CONCEPT IN ANTIEMETIC THERAPY - PANEL DISCUSSION .1.. ONCOLOGY, 49(4), 286-287. |
| 1992 |
Olver, I. N., Smyth, J., Morrow, G. R., Soukop, M., de Muller, P. H. M., Buxton, M. J., & Groshen, S. (1992). Antiemetic study design: Desirable objectives, stratifications and analyses. British Journal of Cancer, 66(SUPPL. 19), S30-S37. Scopus14 |
| 1991 |
BALL, D., BISHOP, J., CRENNAN, E., & OLVER, I. (1991). Concurrent Radiotherapy and Carboplatin in Non Small‐Cell Lung Cancer: A Pilot Study Using Conventional and Accelerated Fractionation. Australasian Radiology, 35(1), 66-67. DOI Scopus8 Europe PMC7 |
| 1990 |
Olver, I. N., Reece, P. A., Bishop, J. F., Morris, R. G., Hillcoat, B. L., & Guentert, T. W. (1990). A phase I study of doxifluridine as a five-day stepped-dose continuous infusion. American Journal of Clinical Oncology Cancer Clinical Trials, 13(4), 308-311. DOI Scopus3 WoS3 |
| 1990 |
Bishop, J. F., Kefford, R., Raghavan, D., Zalcberg, J., Stuart-Harris, R., Ball, D., . . . Zimet, A. (1990). Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer. Cancer Chemotherapy and Pharmacology, 25(5), 367-370. DOI Scopus15 WoS20 Europe PMC10 |
| 1990 |
Reece, P. A., Olver, I. N., Morris, R. G., Bishop, J. F., Guentert, T. W., Hill, H. S., & Hillcoat, B. L. (1990). Pharmacokinetic study of doxifluridine given by 5-day stepped-dose infusion. Cancer Chemotherapy and Pharmacology, 25(4), 274-278. DOI Scopus3 WoS3 Europe PMC1 |
| 1990 |
Olver, I. N., Pearl, P., Wiernik, P. H., & Aisner, J. (1990). SMALL BOWEL OBSTRUCTION AS A LATE COMPLICATION OF THE TREATMENT OF HODGKIN'S DISEASE. Australian and New Zealand Journal of Surgery, 60(8), 585-588. DOI Scopus3 WoS1 |
| 1989 |
Abrams, J. S., Tait, N., Silva, H., Eisenberger, M., Van Echo, D. A., Olver, I. N., & Aisner, J. (1989). Phase II trial of N-methylformamide in advanced renal cancer. American Journal of Clinical Oncology Cancer Clinical Trials, 12(1), 41-42. DOI Scopus3 WoS6 Europe PMC2 |
| 1989 |
Olver, I. N., Webster, L. K., Bishop, J. F., Clarke, J., & Hillcoat, B. L. (1989). A dose finding study of prochlorperazine as an antiemetic for cancer chemotherapy. European Journal of Cancer and Clinical Oncology, 25(10), 1457-1461. DOI Scopus19 WoS17 Europe PMC9 |
| 1989 |
Olver, I. N., Dalley, D., Woods, R., Aroney, R., Hughes, P., Bishop, J. F., & Cruickshank, D. (1989). Carboplatin and continuous infusion 5-fluorouracil for advanced head and neck cancer. European Journal of Cancer and Clinical Oncology, 25(2), 173-176. DOI Scopus11 WoS10 Europe PMC9 |
| 1989 |
Hillcoat, B. L., Raghavan, D., Matthews, J., Kefford, R., Yuen, K., Woods, R., . . . McLennan, R. (1989). A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. Journal of Clinical Oncology, 7(6), 706-709. DOI Scopus83 WoS87 Europe PMC57 |
| 1989 |
Olver, I. N., Roos, I. A. G., Thomas, K., & Hillcoat, B. L. (1989). Development of a murine gastric distension model for testing the emetic potential of new drugs and efficacy of antiemetics. Chemico Biological Interactions, 69(4), 353-357. DOI Scopus6 WoS6 Europe PMC4 |
| 1989 |
Bishop, J. F., Raghavan, D., Olver, I. N., Reece, P., Morris, R., & Friedlander, M. L. (1989). A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion. Cancer Chemotherapy and Pharmacology, 24(4), 246-250. DOI Scopus12 WoS12 Europe PMC7 |
| 1988 |
Olver, I. N., Wolf, M. M., Cruickshank, D., Worotniuk, V., Ding, J. C., Cooper, I. A., & Matthews, J. P. (1988). Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in hodgkin's disease. An analysis of long‐term follow‐up. Cancer, 62(2), 233-239. DOI Scopus32 WoS25 Europe PMC18 |
| 1988 |
Olver, I. N. (1988). The optimal management of cytotoxic-drug extravasation: solving the burning question.. Medical Journal of Australia, 149(9), 506-507. DOI Scopus2 WoS2 Europe PMC1 |
| 1988 |
Olver, I. N., Aisner, J., Hament, A., Buchanan, L., Bishop, J. F., & Kaplan, R. S. (1988). A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. Journal of Clinical Oncology, 6(11), 1732-1735. DOI Scopus108 WoS72 Europe PMC53 |
| 1987 |
OLVER, I. N., RAGHAVAN, D., BISHOP, J. F., MORSTYN, G., KEFFORD, R., STUARTHARRIS, R., . . . HILLCOAT, B. (1987). CARBOPLATIN AND VP16-213 WITH RADIOTHERAPY (RT) AS INITIAL TREATMENT FOR PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC). INVESTIGATIONAL NEW DRUGS, 5(1), 62. |
| 1987 |
MORRIS, R. G., REECE, P. A., BISHOP, J. F., OLVER, I. N., & RAGHAVAN, D. (1987). PHASE-I PHARMACOKINETIC STUDY OF THE METHOTREXATE ANALOG, TRIMETREXATE, IN PATIENTS WITH ADVANCED CANCER. MEDICAL AND PEDIATRIC ONCOLOGY, 15(3), 124. |
| 1987 |
OLVER, I. N., BISHOP, J. F., RAGHAVAN, D., REECE, P., & MORRIS, R. (1987). PHASE-I STUDY OF TRIMETREXATE (TMTX) AS A 5 DAY CONTINUOUS INFUSION. MEDICAL AND PEDIATRIC ONCOLOGY, 15(3), 151. WoS2 |
| 1987 |
Reece, P. A., Bishop, J. F., Olver, I. N., Stafford, I., Hillocat, B. L., & Morstyn, G. (1987). Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma. Cancer Chemotherapy and Pharmacology, 19(4), 326-330. DOI Scopus33 WoS36 Europe PMC17 |
| 1987 |
OLVER, I. N., ROOS, I. A., THOMAS, K., & HILLCOAT, B. L. (1987). THE EFFECT OF ESCALATING DOSES OF PROCHLORPERAZINE ON CISPLATINUM (DDP) INDUCED GASTRIC DISTENSION IN MICE. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 28, 430. WoS1 |
| 1987 |
Reece, P. A., & Morris, R. G. (1987). Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer. Cancer Research, 47(11), 2996-2999. Scopus21 WoS22 Europe PMC9 |
| 1987 |
Bishop, J. F., Raghavan, D., Stuart-Harris, R., Morstyn, G., Aroney, R., Kefford, R., . . . Fox, R. (1987). Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer. Journal of Clinical Oncology, 5(10), 1574-1578. DOI Scopus110 WoS95 Europe PMC60 |
| 1986 |
Olver, I. N. (1986). Should chemotherapy be standard treatment for non-small-cell lung cancer?. Medical Journal of Australia, 144(13), 675-676. DOI Scopus1 WoS2 Europe PMC1 |
| 1986 |
BISHOP, J. F., STUARTHARRIS, R., RAGHAVAN, D., OLVER, I., BALL, D., MORSTYN, G., . . . KEFFORD, R. (1986). CARBOPLATIN (CBDCA, JM8 VP16-213 IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC). AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 16(4), 621. WoS2 |
| 1986 |
Olver, I. N., Donehower, R. C., van Echo, D. A., Ettinger, D. S., & Aisner, J. (1986). Phase II trial of carboplatin in non-small cell lung cancer. Cancer Treatment Reports, 70(3), 421-422. Scopus41 WoS36 Europe PMC21 |
| 1986 |
Olver, I. N., Simon, R. M., & Aisner, J. (1986). Antiemetic studies: A methodological discussion. Cancer Treatment Reports, 70(5), 555-563. Scopus73 WoS71 Europe PMC41 |
| 1985 |
WOLF, M. M., COOPER, I. A., OLVER, I. N., LIEW, K. H., DING, J. C., & MADIGAN, J. P. (1985). NON‐HODGKIN'S LYMPHOMA INVOLVING THE CENTRAL NERVOUS SYSTEM. Australian and New Zealand Journal of Medicine, 15(1), 16-21. DOI Scopus24 WoS23 Europe PMC16 |
| 1984 |
Bishop, J. F., Olver, I. N., Wolf, M. M., Matthews, J. P., Long, M., Bingham, J., . . . Cooper, I. A. (1984). Lorazepam: A randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine. Journal of Clinical Oncology, 2(6), 691-695. DOI Scopus49 WoS62 Europe PMC32 |
| 1983 |
OLVER, I. N., WOLF, M. M., BISHOP, J. F., DING, J. C., COOPER, I. A., & MATTHEWS, J. P. (1983). TREATMENT OF ADVANCED MOPP RESISTANT HODGKINS-DISEASE WITH ABVP. MEDICAL AND PEDIATRIC ONCOLOGY, 11(3), 215. |
| 1983 |
OLVER, I. N., WOLF, M. M., BISHOP, J. F., DING, J. C., COOPER, I. A., & MATTHEWS, J. (1983). ADRIAMYCIN COMBINATIONS AS SALVAGE THERAPY IN ADVANCED MOPP‐RESISTANT HODGKIN'S DISEASE. Australian and New Zealand Journal of Medicine, 13(4), 369-373. DOI Scopus3 WoS2 Europe PMC3 |
| 1983 |
Olver, I. N., & Schwarz, M. A. (1983). Use of dimethyl sulfoxide in limiting tissue damage caused by extravasation of doxorubicin. Cancer Treatment Reports, 67(4), 407-408. Scopus30 WoS29 Europe PMC20 |
| 1983 |
Olver, I. N., Schwarz, M. A., Westmore, D. D., & Masterton, J. P. (1983). COMPLETE REMISSION IN EXTRAGONADAL SEMINOMA PRIMARILY TREATED WITH CHEMOTHERAPY AND RESTAGED BY RETROPERITONEAL NODAL DISSECTION. Australian and New Zealand Journal of Surgery, 53(3), 277-280. DOI Scopus1 Europe PMC1 |
| 1980 |
Olver, I. N., Jennings, G. L., Bobik, A., & Esler, M. (1980). Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension. British Medical Journal, 281(6235), 275-276. DOI Scopus18 WoS17 Europe PMC13 |